Fertilizer and manufacturing method thereof
Patent Information
- Application Number
- JP2024504688
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Filing Date
- 2023-10-25
- Publication Date
- 2024-12-09
AI Technical Summary
Conventional bone-based fertilizers, especially those treated with high-temperature or high-pressure methods, are costly, difficult to control, and have limited location requirements, leading to slow-release and uneven fertilizer distribution, making them unsuitable for hydroponic cultivation and foliar spraying. Additionally, they often have low inorganic content and generate odors during decomposition.
A method for producing a novel fertilizer using bone tissue decomposition products without high-temperature or high-pressure treatment, involving acid and protease treatments to create a liquid fertilizer that can be easily produced and applied, with options for solidification through freeze-drying or mixing with existing fertilizers.
The method results in a high-value-added, fast-acting fertilizer with improved plant growth promotion, suitable for hydroponic cultivation and foliar spraying, while reducing production costs and environmental impact.
Abstract
Description
Fertilizer and its manufacturing method
[0001] The present invention relates to a fertilizer and a method for producing the same.
[0002] Bone meal produced through high-temperature or high-pressure treatment has been known as a fertilizer made from bone tissue (see, for example, Patent Document 1).
[0003] Japanese Patent Application Laid-Open No. 2005-247616
[0004] In addition to phosphate, bone tissue is rich in inorganic components (e.g., calcium, potassium, sodium, vitamins) and organic components (e.g., proteins, proteoglycans, fatty acids, polysaccharides, monosaccharides). Furthermore, bone tissue contains bone-related cells (e.g., osteocytes, osteoblasts, osteoclasts); immune cells (e.g., T cells, macrophages, leukocytes); remnants of red blood cells, adipocytes, and stem cells; and bone marrow and blood components remaining in bone tissue. Bone tissue is a complex of diverse inorganic and organic components. In addition to phosphate, bone tissue decomposition products contain multiple molecules effective for plant growth, potentially creating synergistic effects. Therefore, fertilizers containing bone tissue decomposition products could potentially become high-value-added products. Conventional fertilizers include microbial decomposition of food waste and leaf mold compost. However, food waste contains relatively low inorganic components, and the resulting fertilizers tend to have low inorganic content. Furthermore, the long time required for microbial decomposition of food waste and the resulting odor are major issues. Furthermore, existing bone-derived fertilizers are slow-acting and often require several years of soil improvement. Therefore, there has been a need for a fast-acting, simple, and inexpensive fertilizer that promotes plant growth.
[0005] However, production methods using high-temperature or high-pressure treatment, such as the technology described in Patent Document 1, incur high operating costs, make production control difficult, and limit the location of production plants. Therefore, the inventors came up with the idea of decomposing bone tissue without high-temperature or high-pressure treatment and using the resulting bone tissue decomposition product as fertilizer. In this specification, "fertilizer" refers to both solid and liquid fertilizers. The bone tissue decomposition product may be diluted to form a liquid fertilizer, or may be subjected to processes such as freeze-drying or air-drying to form a solid fertilizer. Furthermore, the bone tissue decomposition product may be sprayed or immersed in an existing solid fertilizer to form a fertilizer.
[0006] Furthermore, existing fertilizers made from bone tissue, including bone meal treated at high temperatures or high pressures, are solid fertilizers. Solid fertilizers are mixed into fertilizer soil and are therefore unsuitable for hydroponic cultivation. If solid fertilizers were used in hydroponic cultivation, the dissolution rates of the fertilizers would vary, potentially resulting in uneven fertilizer concentrations in some areas and insufficient fertilizer in others. Furthermore, solid fertilizers cannot be used for foliar application or other fertilization methods, and their plant growth effects are slow-acting. Thus, existing solid fertilizers made from bone tissue have several drawbacks.
[0007] One aspect of the present invention aims to provide a novel fertilizer (e.g., liquid fertilizer) containing bone tissue digest.
[0008] <1> A method for producing a phosphoric acid-containing fertilizer, comprising one or more of the following steps 1, 2, and 3: Step 1: treating bone tissue with a solution containing both an acid and a protease, and producing a fertilizer from the resulting bone solubilized solution A; Step 2: treating bone tissue with an acid, and producing a fertilizer from the resulting acid extract; Step 3: treating the acid-treated bone tissue with a protease, and producing a fertilizer from the resulting protease-treated solution; <2> The production method according to <1>, which includes steps 2 and 3, and further comprises the following step 4: Step 4: mixing the acid extract and the protease-treated solution, and producing a fertilizer from the resulting bone solubilized solution B; <3> The production method according to <1> or <2>, which includes step 1 or step 2, and which involves acid-treating the bone tissue with one or more acids selected from the group consisting of nitric acid, hydrochloric acid, formic acid, and sulfuric acid. <4> The manufacturing method according to any one of <1> to <3>, comprising step 1 or step 3, in which the bone tissue is protease-treated with a protease having an optimum pH of 1.5 to 8.0. <5> The manufacturing method according to any one of <1> to <4>, in which the bone tissue is acid-treated at 5 to 60°C. <6> The manufacturing method according to any one of <1> to <5>, in which the bone tissue is acid-treated with 0.6 to 2.0 mol / L of acid. <7> The manufacturing method according to any one of <1> to <6>, in which the bone tissue is acid-treated for 6 to 48 hours. <8> The manufacturing method according to any one of <1> to <7>, further comprising, prior to step 1 or step 2, a step of pretreating the bone tissue, wherein the pretreatment is one or more selected from the group consisting of heating the bone tissue, heating the bone tissue under pressure, and irradiating the bone tissue with microwaves. <9> The manufacturing method according to any one of <1> to <8>, wherein proteins contained in the bone tissue are denatured in the pretreatment step. <10> A fertilizer obtained by the manufacturing method according to any one of <1> to <9>. <11> The fertilizer according to <10>, which is a liquid fertilizer.<12> A fertilizer comprising phosphoric acid and a peptide fragment derived from one or more selected from the group consisting of type I collagen, alpha-2-HS-glycoprotein, periostin, biglycan, and SPARC. <13> A fertilizer according to <12>, in which the peptide fragment has lost the activity of the protein from which it is derived. <14> The fertilizer according to <12> or <13>, in which the molecular weight of the peptide fragment is 10,000 Da or less. <15> The fertilizer according to any of <12> to <14>, in which the concentration of the phosphoric acid contained in the fertilizer is 280 mM or more.
[0009] According to one aspect of the present invention, there is provided a novel fertilizer (e.g., liquid fertilizer) containing bone tissue digest.
[0010] 1 is a flowchart showing an example of a method for producing a fertilizer according to one embodiment of the present invention. FIG. 2 is a flowchart showing another example of a method for producing a fertilizer according to one embodiment of the present invention. FIG. 3 is a flowchart showing an example of a method for producing phosphoric acid according to one embodiment of the present invention. FIG. 4 is a diagram showing the results of treating bone tissue obtained by acid-treating pork bones with nitric acid with a protease. FIG. 5 is a diagram showing the results of treating bone tissue obtained by acid-treating pork bones with nitric acid or hydrochloric acid with actinidine. FIG. 6 is a diagram showing the results of preparing bone solubilization solution A using various acids and proteases without solution exchange. FIG. 7 is a diagram showing the results of an experiment investigating the plant growth effect of an acid extract. FIG. 8 is a diagram showing the results of an experiment investigating the plant growth effect of an acid extract, a protease-treated solution, or bone solubilization solution A. FIG. 9 is a diagram showing the results of an experiment comparing the plant growth effect of bone solubilization solution A and a commercially available culture solution. FIG. 10 is a diagram showing the results of an experiment comparing the plant growth effect of bone solubilization solution A and a commercially available culture solution. FIG. 11 is a diagram showing the results of an experiment comparing the change in expression level of stress resistance-related genes caused by bone solubilization solution A and a commercially available liquid fertilizer. 1 shows the results of an experiment comparing changes in the expression levels of stress tolerance-related genes caused by bone solubilization solution A or a commercially available liquid fertilizer. 2 shows the effect of pretreatment of bone tissue on the amount of phosphate contained in an acid extract. 3 shows the results of electrophoretic analysis of protein components contained in an acid extract. 4 shows the results of preparation of a protease-treated solution using various proteases. 5 shows the results of electrophoretic analysis of protein components contained in a protease-treated solution. 6 shows the results of preparation of bone solubilization solution A without solution exchange using various acids and proteases. 7 shows the results of analysis of differentially expressed genes in leaves of sprouts grown for 5 days with bone solubilization solution B or a commercially available liquid fertilizer. 8 shows the results of analysis of differentially expressed genes in roots of sprouts grown for 5 days with a mixture of bone solubilization solution B and a commercially available liquid fertilizer, or with only a commercially available liquid fertilizer. Fig. 1 shows the results of analyzing genes with differential expression in leaves of sprouts grown for five days with a mixture of bone solubilizing solution B and commercially available liquid fertilizer, or with commercially available liquid fertilizer alone. Fig. 2 shows an elution curve showing the results of phosphoric acid extraction using commercially available bone powder as a raw material.This figure shows the results of producing liquid fertilizer using commercially available bone meal as a raw material. Neurase F3G was used as the protease. This figure shows the results of producing liquid fertilizer using commercially available bone meal as a raw material. Papain was used as the protease.
[0011] 1. Fertilizer Production Method A fertilizer production method according to one aspect of the present invention includes one or more of the following steps 1 to 3. In one embodiment, the fertilizer production method further includes the following step 4. Steps 2, 3, 4, and 1 will be described in detail below in this order.
[0012] Step 1: A step of treating bone tissue with a solution containing both acid and protease, and producing a fertilizer from the resulting bone solubilized solution A. Step 2: A step of treating bone tissue with acid, and producing a fertilizer from the resulting acid extract. Step 3: A step of treating the acid-treated bone tissue with protease, and producing a fertilizer from the resulting protease-treated solution. Step 4: A step of mixing the acid extract and the protease-treated solution, and producing a fertilizer from the resulting bone solubilized solution B.
[0013] [1.1. Step 2] Step 2 is a step of treating bone tissue with acid and producing a fertilizer from the resulting acid extract. In step 2, inorganic components are mainly separated from the bone tissue and eluted into the acid extract. A fertilizer is produced from the resulting acid extract. The acid extract itself may be used as the fertilizer, or bone solubilized solution B mixed with a protease treatment solution may be used as the fertilizer.
[0014] The bone tissue to be subjected to step 2 may be derived from any organism. Examples of organisms include mammals, birds, amphibians, and fish. For mass production of fertilizer, it is preferable to be able to obtain a large amount of bone tissue as a raw material for the fertilizer, and for example, bone tissue from livestock (such as cows, pigs, sheep, and chickens) is preferably used. The bone tissue may be pre-shredded or crushed before the acid treatment. This allows for more efficient decomposition of the bone tissue, which may shorten the production time.
[0015] The acid used to treat the bone tissue in step 2 is not particularly limited. Examples of acids include hydrochloric acid, nitric acid, formic acid, sulfuric acid, and trichloroacetic acid. An acidic decalcifying solution such as Planck-Lycros solution may also be used. From the viewpoint of availability, one or more acids selected from the group consisting of nitric acid, hydrochloric acid, formic acid, and sulfuric acid are preferred. From the viewpoint of phosphoric acid recovery efficiency, one or more acids selected from the group consisting of hydrochloric acid, sulfuric acid, and nitric acid are preferred, and one or more acids selected from the group consisting of hydrochloric acid and nitric acid are more preferred. From the viewpoint of calcium recovery efficiency, one or more acids selected from the group consisting of hydrochloric acid and formic acid are preferred. Two or more acids may be mixed in an appropriate ratio and used.
[0016] In step 2, the bone tissue may be treated with an acid solution prepared by diluting an acid in a solvent. Examples of the solvent include water, lower alcohols, glycerol, propane-1,2-diol, and 1,3-propanediol. Two or more types of solutions may be mixed in an appropriate ratio.
[0017] The acid concentration can be appropriately determined depending on the volume of bone tissue to be treated with acid. When the volume of bone tissue is small, it can be treated with a low concentration of acid. When the volume of bone tissue is large, a high concentration of acid is preferred. When acid treatment is performed with a low concentration of acid, it is preferable to treat pulverized bone tissue. However, even when the volume of bone tissue is large, inorganic components can be sufficiently extracted by increasing the acid concentration and immersing for a long period of time. For example, when the volume of bone tissue is several cm 3 When the following crushed bone material is used as the raw material, the lower limit of the acid concentration in step 2 may be 0.6 mol / L or more, 0.7 mol / L or more, 0.8 mol / L or more, or 0.9 mol / L or more. The upper limit of the acid concentration in step 2 may be 2.0 mol / L or less, 1.5 mol / L or less, 1.0 mol / L or less, or 0.9 mol / L or less. When the acid concentration is within the above range, inorganic components can be extracted efficiently, and the cost of neutralizing the acid extract can be reduced because the acid concentration is not too high.
[0018] Examples of suitable acid concentrations when treating pulverized bone tissue with acid are as follows: When the acid is nitric acid, the lower limit of the nitric acid concentration is preferably 0.6 mol / L or more, more preferably 0.7 mol / L or more; The upper limit of the nitric acid concentration is preferably 1.0 mol / L or less, more preferably 0.9 mol / L or less; When the acid is hydrochloric acid, the lower limit of the hydrochloric acid concentration is preferably 0.8 mol / L or more, more preferably 0.9 mol / L or more; The upper limit of the hydrochloric acid concentration is preferably 1.2 mol / L or less, more preferably 1.1 mol / L or less; When the acid is formic acid, the lower limit of the formic acid concentration is preferably 0.8 mol / L or more, more preferably 0.9 mol / L or more; The upper limit of the formic .... When the acid is sulfuric acid, the lower limit of the sulfuric acid concentration is preferably 0.8 mol / L or more, more preferably 0.9 mol / L or more. The upper limit of the sulfuric acid concentration is preferably 1.2 mol / L or less, more preferably 1.1 mol / L or less. However, the above concentrations are examples of suitable concentrations when bone tissue is pulverized, and when bone tissue with a larger volume is used as the raw material, the acid concentration may be higher.
[0019] For example, a volume of several cm 3 When the following crushed bone material is used as the raw material, the lower limit of the extraction time in step 2 is preferably 6 hours or more, more preferably 8 hours or more, and even more preferably 10 hours or more. The upper limit of the extraction time in step 2 is preferably 48 hours or less, more preferably 24 hours or less, and even more preferably 14 hours or less. If the extraction time is within the above range, inorganic components contained in the bone tissue can be sufficiently extracted.
[0020] For example, a volume of several cm 3 When crushed bones described below are used as the raw material, the temperature of the acid treatment in step 2 is preferably 5 to 60°C. Carrying out the acid treatment within the above temperature range can reduce the generation of unpleasant odors associated with the acid treatment. This also mitigates the location requirements for the fertilizer manufacturing plant. Furthermore, adjusting the temperature to 60°C or below does not require expensive special equipment; a constant temperature can be maintained using a water bath or incubator.
[0021] In step 2, in addition to the acid, a chelating agent capable of capturing calcium ions may be added. Alternatively, in step 2, the bone tissue may be treated with a chelating agent before or after the acid treatment (the solutions may or may not be exchanged between the acid treatment and the chelating agent treatment). Examples of chelating agents include ethylenediaminetetraacetic acid (EDTA, CAS Registry Number: 60-00-4), glycol ether diaminetetraacetic acid (EGTA, CAS Registry Number: 67-42-5), and ethylenediamine-N,N'-disuccinic acid (EDDS, CAS Registry Number: 20846-91-7). In step 2, the pH of the solution containing the chelating agent is preferably 6.0 to 8.0. For example, when the volume of the solution is several cm 3 When the following crushed bone material is used as the raw material, the lower limit of the chelating agent concentration in step 2 may be 0.1 mol / L or more, 0.2 mol / L or more, 0.3 mol / L or more, or 0.4 mol / L or more. The upper limit of the chelating agent concentration in step 2 may be 0.9 mol / L or less, 0.8 mol / L or less, 0.7 mol / L or less, or 0.6 mol / L or less.
[0022] In step 2, at least a portion of the calcium may be removed after the acid treatment. Examples of methods for removing calcium include neutralizing the acid extract (resulting in calcium phosphate precipitation), adding sulfuric acid or a sulfate salt (resulting in calcium sulfate precipitation), adding carbonic acid or a carbonate salt (resulting in calcium carbonate or calcium bicarbonate precipitation), and adding a bicarbonate salt (resulting in calcium carbonate or calcium bicarbonate precipitation).
[0023] The pretreatment step described below tends to increase the phosphoric acid concentration in the acid extract obtained in step 2. The concentration of phosphoric acid contained in the acid extract can be, for example, 280 mM or more, 300 mM or more, or 320 mM or more.
[0024] [1.2. Step 3] Step 3 is a step of treating the acid-treated bone tissue with a protease and producing a fertilizer from the resulting protease-treated solution. The fertilizer is produced from the resulting protease-treated solution. The protease-treated solution itself may be used as the fertilizer, or bone solubilized solution B mixed with the acid extract may be used as the fertilizer.
[0025] There is no particular limitation on the protease used in step 3. Examples of proteases include serine proteases, cysteine proteases, aspartic acid proteases, glutamic acid proteases, and metalloproteases.
[0026] Specific examples of proteases include trypsin [EC 3.4.21.4], chymotrypsin [EC 3.4.21.1], [EC 3.4.21.2], pepsin [EC 3.4.23.1], ecolysin [EC 3.4.23.19], papain [EC 3.4.22.2], ficin [EC 3.4.22.3], actinidyne [EC 3.4.22.14], bromelain [EC 3.4.22.32], cathepsin B [EC 3.4.22.1], cathepsin H [EC 3.4.22.16], cathepsin K [EC 3.4.22.38], cathepsin L [EC 3.4.22.15], and cathepsin S [EC 3.4.22.27], and thermolysin [EC 3.4.24.27].
[0027] As the protease, a commercially available enzyme preparation may be used. Examples of such preparations include Neurase F3G (derived from Rhizopus niveus), Orientase AY (derived from Aspergillus niger), Tetolase (derived from Aspergillus niger), Sumiteam AP (derived from Aspergillus niger), Denapsin 2P (derived from the genus Aspergillus), Brewer's Clarex (derived from Aspergillus niger), MaxiPro AFP (derived from Aspergillus niger), Protease S "Amano" G (derived from Bacillus stearothermophilus), Protease N "Amano" G (derived from Bacillus subtilis), Protease NL "Amano" (derived from Bacillus subtilis), Protease A "Amano" G (derived from Aspergillus oryzae), Umamizyme (derived from Aspergillus oryzae), Protease P "Amano" 3G (derived from Aspergillus Examples of enzymes that can be used include enzymes derived from Aspergillus melleus, protease M "Amano" SD (derived from Aspergillus oryzae), and peptidase R (derived from Rhizopus oryzae). Alternatively, chemically synthesized enzymes, enzymes produced by genetic engineering techniques, and enzymes extracted from organisms may also be used.
[0028] The protease used in step 3 is preferably a protease having an optimum pH of 1.5 to 8.0. Examples of proteases having an optimum pH of 1.5 to 8.0 include Protease S "Amano" G (optimum pH: 7.0 to 8.5), Protease N "Amano" G (optimum pH: 6.0 to 7.5), Protease NL "Amano" (optimum pH: 6.5 to 7.5), Protease A "Amano" G (optimum pH: 6.0 to 7.5), Umamizyme (optimum pH: 6.0 to 7.5), and Protease M "Amano" G (optimum pH: 3.0 to 6.5). , Protease P "Amano" 3G (optimum pH: 7.0-8.0), Peptidase R "Amano" (optimum pH: 6.0-8.0), Actinidain (optimum pH: 2.5-7.5), Papain (optimum pH: 4.0-9.0), Pepsin (optimum pH: 1.5-3.0), Neurolase F3G (optimum pH: 3.0-5.0), Trypsin (optimum pH: 7.0-9.0), Chymotrypsin (optimum pH: 7.0-9.0). The protease used is more preferably a protease having an optimum pH of 1.5-5.0. Examples of proteases having an optimum pH of 1.5 to 5.0 include Protease M "Amano" (optimum pH: 3.0 to 6.5), Actinidain (optimum pH: 2.5 to 7.5), Papain (optimum pH: 4.0 to 9.0), Pepsin (optimum pH: 1.5 to 3.0), and Neurolase F3G (optimum pH: 3.0 to 5.0). More preferably, the protease used has an optimum pH of 1.5 to 4.0. Examples of proteases having an optimum pH of 1.5 to 4.0 include Actinidain (optimum pH: 2.5 to 7.5), Pepsin (optimum pH: 1.5 to 3.0), and Neurolase F3G (optimum pH: 3.0 to 5.0).
[0029] The concentration of the protease in step 3 can be set appropriately. The lower limit of the protease concentration can be 2 mg / L or more or 10 mg / L or more. The upper limit of the protease concentration can be 100 mg / L or less or 50 mg / L or less.
[0030] The temperature and pH in step 3 can be set appropriately. It is preferable to match them to the optimum temperature and pH of the protease used in order to improve treatment efficiency. Examples of the temperature of the reaction system in step 3 include 20 to 60°C. The lower limit of the temperature of the reaction system in step 2 can be more than 10°C, 20°C or higher, 25°C or higher, 30°C or higher, 35°C or higher, 40°C or higher, 45°C or higher, 50°C or higher, or 55°C or higher. The upper limit of the temperature of the reaction system in step 2 can be 60°C or lower or 55°C or lower.
[0031] In step 3, a salt may be added to the reaction system. The substrate specificity of the protease may change depending on the concentration of the salt added to the reaction system. Therefore, adding a salt to the reaction system can change the components contained in the resulting protease-treated solution.
[0032] Examples of salts to be added to the reaction system in step 3 include chloride salts. Examples of chloride salts include NaCl, KCl, LiCl, and MgCl. 2 The lower limit of the concentration of the salt added to the reaction system in step 3 may be more than 0 mmol / L, 20 mmol / L or more, 100 mmol / L or more, 150 mmol / L or more, 200 mmol / L or more, 500 mmol / L or more, 1000 mmol / L or more, 1500 mmol / L or more, or 2000 mmol / L or more. The upper limit of the concentration of the salt added to the reaction system in step 3 may be 4000 mmol / L or less or 2000 mmol / L or less.
[0033] In one embodiment, the size of the peptide fragments produced in step 3 is 10,000 Da or less, 8,000 Da or less, 6,000 Da or less, or 4,000 Da or less. Peptide fragments cleaved to such sizes are likely to lose their physiological activity. Furthermore, peptide fragments cleaved to such sizes are easily absorbed by plants as nutrients and may function as active ingredients in fertilizers. In one embodiment, the peptide fragments are derived from one or more selected from the group consisting of type I collagen, alpha-2-HS-glycoprotein, periostin, biglycan, and SPARC.
[0034] [1.3. Step 4] Step 4 is a step of mixing the acid extract obtained in step 2 with the protease-treated solution obtained in step 3 to produce a fertilizer from the resulting bone solubilized solution B. A fertilizer is produced from the resulting bone solubilized solution B. In step 4, the mixing ratio of the acid extract and the protease-treated solution is not particularly limited. The mixing ratio can be appropriately selected so that the resulting bone solubilized solution B has a desired composition.
[0035] [1.4. Step 1] Step 1 is a step in which bone tissue is treated with a solution containing both an acid and a protease, and a fertilizer is produced from the resulting bone solubilized solution A. In step 1, the acid treatment in step 2 and the protease treatment in step 3 proceed simultaneously. In step 1, there is no need to exchange the solutions during the acid treatment and the protease treatment.
[0036] In step 1, the order in which the bone tissue is brought into contact with the acid and protease is not particularly limited. For example, the following orders can be used. Among these orders, order 1 is preferred. Order 1: The bone tissue is immersed in a solution containing an acid, and after a predetermined time has passed, the protease is added to the solution. Before adding the protease, the pH of the solution may be adjusted to the optimal pH for the protease. Order 2: The bone tissue is immersed in a solution containing a protease, and after a predetermined time has passed, the acid is added to the solution. Order 3: A solution containing both an acid and a protease is prepared, and the bone tissue is immersed in the solution.
[0037] For preferred conditions for the acid treatment and protease treatment in step 1, the descriptions in sections [1.1] and [1.2] are incorporated herein by reference.
[0038] [1.5. Other Steps] The method for producing a fertilizer according to one embodiment of the present invention may further include steps that are typically carried out in the production of fertilizers, in addition to steps 1 to 4. Examples of such steps include a pretreatment step, an ingredient addition step, a drying step, a pulverization step, a coating and granulation step, and a packaging step.
[0039] The pretreatment step is a step that precedes step 1 or step 2. In the pretreatment step, the bone tissue, which is the raw material, is pretreated. By carrying out the pretreatment step, the amount of phosphoric acid extracted from the bone tissue can be increased (see Example 4).
[0040] In one embodiment, the pretreatment step involves heating the bone tissue. The heating temperature may be 30° C. or higher, or 40° C. or higher; or 100° C. or lower, or 80° C. or lower. The bone tissue may be heated while immersed in acid.
[0041] In one embodiment, the pretreatment step involves heating the bone tissue under pressure. The pressure may be 200 kPa or more, or 1 MPa or more; or 500 MPa or less, or 800 MPa or less. The heating temperature may be 10°C or more, or 50°C or more; or 120°C or less, or 200°C or less.
[0042] In one embodiment, the pretreatment step involves irradiating the bone tissue with microwaves. Heating, heating under pressure, and microwave irradiation may be performed in any combination. Among these, microwave irradiation is more preferable as the pretreatment step because it can achieve its effect in a short time. The microwave irradiation time may be 5 seconds or more, 10 seconds or more, or 15 seconds or more; or 10 minutes or less, 7 minutes or less, or 5 minutes or less.
[0043] The pretreatment process denatures the proteins contained in bone tissue. Therefore, the fertilizer obtained after the pretreatment process contains denatured proteins (or fragments thereof). Denatured proteins (or fragments thereof) have lost the physiological activity that the original proteins possessed.
[0044] The component addition step is a step of adding additional fertilizer components. Providing the component addition step makes it possible to produce a fertilizer with a composition suitable for the plant being cultivated. Examples of fertilizer components added in the component addition step include potassium components (potassium oxide, potassium hydroxide, potassium chloride, potassium sulfate, etc.), nitrogen components (urea, ammonium nitrate, etc.), magnesium components (magnesium phosphate, magnesium chloride, magnesium sulfate, etc.), vitamins, manganese, boron, iron, copper, zinc, and molybdenum. The acid extract, protease-treated solution, bone solubilized solution A, or bone solubilized solution B may also be mixed with other fertilizers (inorganic fertilizers, organic fertilizers, etc.).
[0045] The drying step is a step of removing excess water from the acid extract, the protease-treated solution, the bone solubilization solution A, or the bone solubilization solution B. A solid or paste-like fertilizer is obtained through the drying step. The solid fertilizer may be cut or crushed into a size and shape that is easy to apply, as needed.
[0046] The coating and granulation process is a process of coating and granulating a solid fertilizer. For example, coating the fertilizer with a silicate compound or the like can adjust the fertilizer release time, prevent immobilization of phosphorus and calcium, prevent the fertilizer from being washed away, and prevent the fertilizer from being damaged by impact.
[0047] The packaging step is a step of packaging the acid extract, the protease-treated solution, the bone solubilized solution A, or the bone solubilized solution B in a container so that it can be distributed or sold as a fertilizer. In the packaging step, the acid extract, the protease-treated solution, the bone solubilized solution A, or the bone solubilized solution B may be combined with instructions for using them as a fertilizer. The instructions may be printed on the container or may be prepared as a physical or electronic document separately from the packaged fertilizer. The instructions may include the fertilizer formulation, the application method and timing, the target crop, etc.
[0048] [1.6. Exemplary Fertilizer Manufacturing Method] An example of a method for manufacturing a fertilizer according to one embodiment of the present invention will be described with reference to an exemplary flowchart.
[0049] 1 is an exemplary flowchart showing a production method including steps 2, 3, and / or 4. In this flowchart, an acid extract is obtained through steps S1, S2, S3, and S4. A protease-treated solution is obtained through steps S1, S2, and S5. Furthermore, bone solubilized solution B is obtained by subjecting the acid extract and protease-treated solution to step S6. The acid extract, protease-treated solution, and bone solubilized solution B can all be used as components of fertilizers or mixed fertilizers. Because the acid extract contains phosphoric acid, an essential nutrient for plants, it can also be used as a fertilizer.
[0050] In step S1, the bone tissue is pretreated. Step S1 is an optional step and may not be performed. Pretreating the bone tissue can increase the amount of phosphoric acid contained in the acid extract. This step is as described in section [1.5].
[0051] In step S2, the bone tissue is treated with acid. The supernatant obtained through step S2 is the acid extract. Fertilizer is produced from the acid extract, which corresponds to step 2 described above. The acid treatment of the bone tissue is as described in section [1.1].
[0052] In step S3, a sulfate, carbonate, or bicarbonate is added. Step S3 is an optional step and may not be performed. Step S3 precipitates calcium ions contained in the acid extract as calcium sulfate, calcium carbonate, or calcium bicarbonate. Examples of sulfates include sodium sulfate, potassium sulfate, ammonium sulfate, and magnesium sulfate. Examples of carbonates include potassium carbonate and ammonium carbonate. Examples of bicarbonates include potassium bicarbonate. Preferably, the sulfate is one or more selected from the group consisting of potassium sulfate, ammonium sulfate, and magnesium sulfate. Preferably, the carbonate is potassium carbonate. Preferably, the bicarbonate is potassium bicarbonate. Using these sulfates, carbonates, or bicarbonates results in potassium, magnesium, and / or ammonium being contained in the acid extract. These components are important nutrients for plants.
[0053] In step S4, the acid extract is neutralized with a base. Step S4 is an optional step and may not be performed. Step S4 returns the acidity of the acid extract from acidic to near-neutral. Examples of bases that can be used include sodium hydroxide and potassium hydroxide. Of these, when potassium hydroxide is used, potassium ions are contained in the acid extract. Since potassium ions are an important nutrient for plants, neutralization with potassium hydroxide is preferred.
[0054] In step S5, the bone tissue that has been subjected to the acid treatment is treated with protease. The treated solution obtained through step S5 is the protease-treated solution. Fertilizer is produced from the protease-treated solution, which is the above-mentioned step 3. The protease treatment and acid treatment of bone tissue are as described in section [1.2].
[0055] In step S6, the acid extract and the protease-treated solution are mixed together to obtain bone solubilized solution B. Fertilizer is produced from bone solubilized solution B, which corresponds to step 4 described above. The preparation of bone solubilized solution B is as described in section [1.3].
[0056] 2 is an exemplary flowchart illustrating a production method including step 1. In this flowchart, bone solubilized solution A is obtained through steps S1, S7, S3, and S4. Bone solubilized solution A can be used as a component of a fertilizer or a mixed fertilizer.
[0057] Steps S1, S3, and S4 have been described above, and therefore will not be described again.
[0058] In step S7, the bone tissue is treated with both acid and protease, thereby obtaining bone solubilized solution A. Fertilizer is produced from bone solubilized solution A, which corresponds to step 1 described above. The preparation of bone solubilized solution A is as described in section [1.4].
[0059] [2. Fertilizer] [2.1. Fertilizer specified by production method] A fertilizer according to one embodiment of the present invention is a fertilizer obtained by the production method of a fertilizer according to one embodiment of the present invention. Therefore, the fertilizer according to one embodiment of the present invention contains an acid extract, a protease-treated solution, and bone solubilization solution A or bone solubilization solution B. Among these, fertilizers containing bone solubilization solution A or bone solubilization solution B are preferred because they have a higher plant growth-promoting effect.
[0060] The lower limit of the proportion of the acid extract, protease treatment liquid, bone solubilization liquid A, or bone solubilization liquid B relative to the total weight of the fertilizer can be 0.01 wt% or more, 0.05 wt% or more, 0.1 wt% or more, 0.5 wt% or more, 1 wt% or more, 5 wt% or more, 10 wt% or more, 20 wt% or more, 30 wt% or more, 40 wt% or more, 50 wt% or more, 60 wt% or more, 70 wt% or more, 80 wt% or more, or 90 wt% or more. The upper limit of the proportion of the acid extract, protease treatment liquid, bone solubilization liquid A, or bone solubilization liquid B relative to the total weight of the fertilizer is 100 wt%. In one embodiment, the fertilizer consists solely of the acid extract, protease treatment liquid, bone solubilization liquid A, bone solubilization liquid B, or any mixture thereof.
[0061] The composition of the fertilizer may be modified as needed. For example, some or all of the phosphorus and calcium may be replaced with calcium dihydrogen phosphate or calcium citrate. This composition allows the timing of fertilizer release to be adjusted so that phosphorus and calcium are supplied in accordance with the growth stage of the plant.
[0062] The fertilizer may be a solid fertilizer or a liquid fertilizer. The acid extract, protease-treated solution, bone solubilized solution A, or bone solubilized solution B is obtained as a liquid, and therefore can be easily processed into a liquid fertilizer. According to a fertilizer production method according to one embodiment of the present invention, bone tissue components (e.g., all components of bone tissue) can be solubilized, and thus a liquid fertilizer rich in components useful for plant growth can be obtained. Furthermore, existing bone-derived solid fertilizers (bone meal) are slow-acting and are often used for soil improvement over several years, whereas liquid fertilizers are expected to be effective immediately. Furthermore, while bone meal is not suitable for hydroponic cultivation, liquid fertilizers can be suitably used for hydroponic cultivation. Liquid fertilizers also have the advantage of being easily applicable to foliar spraying.
[0063] The fertilizer may contain components other than the acid extract, protease treatment solution, bone solubilization solution A, or bone solubilization solution B. Examples of such components include acidic fertilizers, alkaline fertilizers, and other common fertilizers. Examples of acidic fertilizers include ammonium sulfate, superphosphate of lime, potassium sulfate, aluminum sulfate, peat moss, black soil, ash, and alum. Examples of alkaline fertilizers include wood ash, lime nitrogen, Chilean saltpeter, fish fertilizer leaf mold, magnesium lime, organic lime, slaked lime, lime nitrogen, limestone, cement, baking soda, shells, rice husks, and charcoal. Other common fertilizer examples include straw, bark, and molasses. The fertilizer may further contain free amino acids (e.g., gamma-aminobutyric acid), plant growth hormones (e.g., auxin), and trace elements (e.g., magnesium, sulfur, iron, manganese, zinc, copper, boron, and molybdenum).
[0064] [2.2. Fertilizers Identified by Components] A fertilizer according to one embodiment of the present invention contains bone tissue decomposition product. Therefore, it often contains type I collagen, osteocalcin, alpha-2-HS-glycoprotein, periostin, biglycan, SPARC, or degradation peptides thereof, which are major organic components of bone tissue. These components are unlikely to be contained in fertilizers obtained by other production methods. Therefore, a fertilizer containing type I collagen, osteocalcin, alpha-2-HS-glycoprotein, biglycan, SPARC, degradation peptides thereof, or a combination thereof is highly likely to be a fertilizer produced by a production method according to one embodiment of the present invention.
[0065] In one embodiment, the fertilizer contains peptide fragments derived from one or more selected from the group consisting of type I collagen, alpha-2-HS-glycoprotein, periostin, biglycan, and SPARC. A method for producing a fertilizer according to one embodiment of the present invention may include treating bone tissue with a protease (steps S5 and S7). The site of a peptide chain cleaved by a protease is determined uniquely for that protease. Therefore, when a specific protein is treated with a specific protease, the peptide fragments generated by the treatment are uniquely determined. Since each fragment has a different molecular weight, the protein before protease treatment can be identified from the peptide fragments contained in the fertilizer by, for example, mass spectrometry. Therefore, a person skilled in the art can determine whether the peptide fragments contained in the fertilizer are peptide fragments derived from one or more selected from the group consisting of type I collagen, alpha-2-HS-glycoprotein, periostin, biglycan, and SPARC.
[0066] Table 1 shows examples of peptide fragments that can be detected by LC-MS / MS. These peptide fragments are those that can appear when fertilizer is analyzed without trypsin treatment. Because trypsin treatment is not performed, the C-terminus of the peptide fragment is an amino acid that is not Lys or Arg.
[0067]
[0068] In one embodiment, the peptide fragments derived from one or more selected from the group consisting of type I collagen, alpha-2-HS-glycoprotein, periostin, biglycan, and SPARC do not have physiological activity. A method for producing a fertilizer according to one embodiment of the present invention includes multiple steps in which proteins can lose their physiological activity. One is a pretreatment step. In the pretreatment step, the bone tissue is heated, heated under pressure, or irradiated with microwaves, thereby denaturing the proteins and causing them to lose their physiological activity. The other is the protease treatment in steps 1 and 3. Proteins treated with proteases are fragmented and lose their original physiological activity.
[0069] In one embodiment, the size of the peptide fragments derived from one or more selected from the group consisting of type I collagen, alpha-2-HS-glycoprotein, periostin, biglycan, and SPARC is 10,000 Da or less, 8,000 Da or less, 6,000 Da or less, or 4,000 Da or less. Peptide fragments cleaved to such sizes are likely to lose their physiological activity. Furthermore, peptide fragments cleaved to such sizes are easily absorbed by plants as nutrients and may function as active ingredients in fertilizers.
[0070] As used herein, the "biological activities of type I collagen, alpha-2-HS-glycoprotein, periostin, biglycan, and SPARC" are as follows. When fragments derived from these have lost their biological activity, it means that they do not have the following activities: - Biological activity of type I collagen: self-associates to form fibers under physiological conditions. - Biological activity of alpha-2-HS-glycoprotein: binds to calcium ions. - Biological activity of periostin: functions as a cell adhesion molecule for osteoprogenitor cells. - Biological activity of biglycan: binds to type I collagen. - Biological activity of SPARC: promotes type I collagen synthesis in cultured dermal fibroblasts.
[0071] In one embodiment, the fertilizer contains phosphoric acid. In the method for producing a fertilizer according to one embodiment of the present invention, the concentration of phosphoric acid contained in the fertilizer tends to be increased by performing the pretreatment step. The concentration of phosphoric acid contained in the fertilizer may be, for example, 280 mM or more, 300 mM or more, or 320 mM or more.
[0072] In one embodiment, the fertilizer includes both phosphate and a peptide fragment derived from one or more selected from the group consisting of type I collagen, alpha-2-HS-glycoprotein, periostin, biglycan, and SPARC.
[0073] 3. Method for Producing Phosphoric Acid Another aspect of the present invention relates to a method for producing phosphoric acid using bone tissue as a raw material. The method for producing phosphoric acid includes, for example, a step of purifying calcium phosphate and a step of removing calcium.
[0074] An example of a calcium phosphate production process is as follows: 1. An alkaline solution is added to the acid extract obtained in step 2 to neutralize it. This results in a precipitate. 2. An acid solution (such as an aqueous hydrochloric acid solution) is added to the precipitate to re-solubilize it. 3. Steps 1 and 2 are repeated to purify the calcium phosphate.
[0075] In the calcium removal step, calcium is removed by adding a chelating agent to the purified calcium phosphate solution. As another example, calcium may be precipitated as calcium sulfate or calcium carbonate by adding one or more selected from the group consisting of sulfates, carbonates, and bicarbonates to the purified calcium phosphate solution. Examples of sulfates, carbonates, and bicarbonates include sodium sulfate, potassium sulfate, ammonium sulfate, magnesium sulfate, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, ammonium carbonate, or a mixture of any of these components. The reagents added to the calcium phosphate solution may be added as powder or as a solution (e.g., an aqueous solution). The above-mentioned method can be applied to acidic solutions at room temperature, making calcium removal easy.
[0076] [3.1. Exemplary Methods for Producing Phosphoric Acid] There are two possible methods for producing phosphoric acid from bone tissue. One is a method in which bones are incinerated to produce bone ash, and phosphoric acid is purified from the bone ash. The process of purifying phosphoric acid from bone ash employs the conventional method of purifying phosphoric acid from phosphate rock. However, this method consumes a large amount of energy and produces CO 2 This would also increase production, making it unsuitable for achieving the SDGs.
[0077] Another manufacturing method is illustrated in the flowchart of FIG. 3. In addition to phosphoric acid, bone tissue contains inorganic components such as calcium and organic components such as collagen. In the method illustrated in FIG. 3, phosphoric acid is dissolved in steps S11 and S12, and components other than phosphoric acid and calcium are removed in steps S13 and S14. Steps S13 and S14 may be repeated, and the number of repetitions can be set appropriately. In step S15, sulfate, carbonate, or bicarbonate is added to remove calcium. The calcium sulfate, calcium carbonate, or calcium bicarbonate produced in step S15 may be used as agricultural fertilizer or industrial raw material. Each step is described in detail below.
[0078] In step S11, the bone tissue is pretreated. Step S11 is an optional step and may not be performed. Pretreating the bone tissue can increase the amount of phosphoric acid contained in the acid extract. This step is the same as step S1 described above, and details are as explained in section [1.5].
[0079] In step S12, the bone tissue is treated with acid. This step yields an acid extract. This step is the same as step S2 described above, and the conditions for the acid treatment are as described in section [1.1].
[0080] In step S13, the acid extract is neutralized with a base. In step S13, the phosphate ions contained in the acid extract are precipitated as calcium phosphate, and components derived from bone impurities are contained in the supernatant. Therefore, phosphoric acid can be purified by recovering the precipitate. Examples of bases that can be used include sodium hydroxide and potassium hydroxide.
[0081] In step S14, an acid is added to the calcium phosphate precipitate, which redissolves the calcium phosphate that was precipitated. Examples of acids that can be used include hydrochloric acid, nitric acid, and formic acid.
[0082] Steps S13 and S14 may be repeated. Repeating these steps increases the purity of the phosphoric acid. Steps S13 and S14 may be repeated, for example, two or more times, three or more times, four or more times, or five or more times. From the viewpoint of economy, steps S13 and S14 may be repeated, for example, ten or fewer times. After repeating steps S13 and S14, a washing treatment may be performed as many times as necessary before proceeding to step S15, in which unnecessary components contained in the calcium phosphate precipitate are washed away with pure water.
[0083] In step S15, a sulfate, carbonate, or bicarbonate is added to the calcium phosphate solution. This causes calcium ions in the solution to precipitate as calcium sulfate, calcium carbonate, or calcium bicarbonate. The precipitated calcium sulfate, calcium carbonate, or calcium bicarbonate is removed by centrifugation or other methods. Examples of sulfates include one or more selected from sodium sulfate, potassium sulfate, ammonium sulfate, and magnesium sulfate. Examples of carbonates include one or more selected from sodium carbonate, potassium carbonate, and ammonium carbonate. Examples of bicarbonates include one or more selected from sodium bicarbonate and potassium bicarbonate. Two or more of sulfates, carbonates, and bicarbonates can also be arbitrarily combined. Adding sulfates rather than sulfuric acid in step S15 has the following advantages: Since no liquid is added, the volume increase of the reaction system can be reduced. Since the reaction system does not become strongly acidic, only a small amount of base is required for neutralization. It is highly safe. It also has a high calcium removal rate.
[0084] The amount of sulfate, carbonate, or bicarbonate added in step S15 can be appropriately determined by those skilled in the art. The amount of sulfate, carbonate, or bicarbonate added may be, for example, an amount that results in a sulfate, carbonate, or bicarbonate concentration in the reaction system of 0.2 M or more, 0.4 M or more, 0.6 M or more, 0.8 M or more, or 1.0 M or more. The greater the amount of sulfate, carbonate, or bicarbonate added, the less residual calcium there will be. The upper limit of the amount of sulfate, carbonate, or bicarbonate added may be, for example, an amount that results in a sulfate concentration in the reaction system of 3.0 M or less, 2.0 M or less, or 1.0 M or less.
[0085] In step S15, due to the solubility product, small amounts of sulfate ions, carbonate ions, or bicarbonate ions remain in the supernatant. When removing these ions, carbonate ions or bicarbonate ions are converted to carbon dioxide by heating, and therefore can be easily removed. Therefore, the salt added in step S15 is preferably one or more selected from the group consisting of carbonates and bicarbonates.
[0086] In step S16, the supernatant after calcium removal is purified. The supernatant may contain cations such as sodium ions contained in the sulfate salt, and anions such as chloride ions. High-purity phosphoric acid can be obtained by adsorbing these ions onto, for example, an ion exchange resin. If carbonate ions or bicarbonate ions are present, they can be converted to carbon dioxide by heating, thereby removing the ions from the system.
[0087] The present invention is not limited to the above-described embodiments, and various modifications are possible within the scope of the claims. Embodiments obtained by appropriately combining the technical means disclosed in different embodiments are also included in the technical scope of the present invention.
[0088] Example 1: Preparation of Fertilizer Containing Bone Tissue Decomposition Product Example 1-1: Preparation of Acid Extract with Nitric Acid and Component Analysis Bone tissue was treated with nitric acid to obtain an acid extract according to the following procedure. 1. Pork bones obtained from a slaughterhouse were finely ground using a mill (IKA TUBE MILL 100, IKA JAPAN Co., Ltd.). 2. 40 mL of aqueous nitric acid solution was added to 3 g of wet weight of pork bones, and the bones were immersed at 20°C. The concentrations of the aqueous nitric acid solution were 0.3 mol / L, 0.5 mol / L, 0.75 mol / L, or 1.0 mol / L. The immersion time was 12, 24, or 48 hours. 3. The supernatant was collected and used as the acid extract.
[0089] Example 1-2: Preparation of Acid Extract with Hydrochloric Acid and Component Analysis Bone tissue was treated with hydrochloric acid to obtain an acid extract according to the following procedure. 1. Pork bones obtained from a slaughterhouse were finely pulverized using a mill (IKA TUBE MILL 100, IKA JAPAN Co., Ltd.). 2. 35 mL of aqueous hydrochloric acid was added to 2 g of wet weight of pork bones, and the bones were immersed at 20°C. The concentration of the aqueous hydrochloric acid solution was 0.3 mol / L, 0.5 mol / L, or 1.0 mol / L. The immersion time was 6 hours, 12 hours, or 24 hours. 3. The supernatant was collected and used as the acid extract.
[0090] [Example 1-3: Preparation of acid extract using formic acid and component analysis] Bone tissue was treated with formic acid to obtain an acid extract according to the following procedure. 1. Pork bones obtained from a slaughterhouse were finely pulverized using a mill (IKA TUBE MILL 100, IKA JAPAN Co., Ltd.). 2. 35 mL of aqueous formic acid was added to 2 g of wet weight of pork bones, and the bones were immersed at 20°C. The concentration of the aqueous formic acid solution was 0.3 mol / L, 0.5 mol / L, or 1.0 mol / L. The immersion time was 6, 12, or 24 hours. 3. The supernatant was collected and used as the acid extract.
[0091] [Example 1-4: Preparation of Acid Extract with Sulfuric Acid and Component Analysis] Bone tissue was treated with sulfuric acid and an acid extract was obtained according to the following procedure. 1. Pork bones obtained from a slaughterhouse were finely pulverized using a mill (IKA TUBE MILL 100, IKA JAPAN Co., Ltd.). 2. 35 mL of aqueous sulfuric acid was added to 2 g of wet weight of pork bones, and the bones were immersed at 20°C. The concentration of the aqueous sulfuric acid solution was 0.3 mol / L, 0.5 mol / L, or 1.0 mol / L. The immersion time was 6 hours, 12 hours, or 24 hours. 3. The supernatant was collected and used as the acid extract.
[0092] Table 2 shows the results of analyzing the total phosphorus in the acid extract obtained. The component analysis was outsourced to Kurita Analysis Center Co., Ltd. Table 2 shows the measurement results of total phosphorus (mg) converted per 1 g of wet bone weight. The analysis results were summarized for each acid, nitric acid, hydrochloric acid, formic acid, or sulfuric acid, by concentration and immersion time. It was shown that most of the phosphorus could be recovered in about 24 hours with any acid aqueous solution. It was also shown that sufficient phosphorus could be recovered with an acid concentration of about 1 mol / L. Of the four acids examined, hydrochloric acid and sulfuric acid had the highest phosphorus recovery efficiency. Table 2 shows that approximately 100 mg of phosphorus can be recovered from 1 g of bone tissue.
[0093]
[0094] Table 3 shows the results of analyzing the total calcium content of the acid extract. The component analysis was outsourced to Kurita Analysis Center Co., Ltd. Table 3 shows the total calcium (mg) measured per gram of wet bone. The analytical results were summarized for each acid, including nitric acid, hydrochloric acid, formic acid, and sulfuric acid, along with the immersion time. It was shown that most of the calcium was recovered within approximately 24 hours in the nitric acid, hydrochloric acid, and formic acid solutions. Furthermore, in the sulfuric acid solution, the released calcium formed insoluble calcium sulfate. Therefore, although the analytical results indicated a low calcium concentration, calcium was actually eluted from the bone tissue. It was shown that an acid concentration of approximately 1 mol / L was sufficient for calcium recovery. Of the four acids examined, hydrochloric acid and formic acid had the highest calcium recovery efficiency. Table 3 indicates that approximately 200 mg of calcium could be recovered from 1 g of bone tissue.
[0095]
[0096] [Example 1-5: Preparation of protease treatment solution] The acid-treated bone tissue obtained in Example 1-2 was immersed in a treatment solution containing the following two types of proteases. The protease treatment conditions were: protease concentration: 2% (w / w), temperature: 50°C, pH: optimal pH. - Protease 1: Neurase F3G (Amano Enzyme Inc., protease derived from Rhizopus niveus filamentous fungus) - Protease 2: Pepsin (Sigma Aldrich, aspartic acid protease)
[0097] The results are shown in Figure 4. In Figure 4, A represents the results of treatment with protease 1, and B represents the results of treatment with protease 2. The treatment times were 3.5 hours, 19 hours, or 24 hours. The transparency of the treatment solution and the remaining bone tissue were visually inspected, and the results are as follows: After 3.5 hours: In both systems treated with proteases, the bone tissue had almost completely disappeared. After 24 hours: In both systems treated with proteases, the bone tissue had completely disappeared, and the transparency of the protease-treated solution had also increased.
[0098] Thus, it was found that a protease-treated solution can be obtained by treating acid-treated bone tissue with a commercially available protease.
[0099] [Examples 1-6: Preparation of Protease-Treated Solution and Component Analysis] A protease-treated solution was obtained according to the following procedure. 1. Bone tissue was immersed in a 1 mol / L aqueous nitric acid solution or a 1 mol / L aqueous hydrochloric acid solution for 48 hours for acid treatment. 2. The resulting treatment solution was separated into an acid extract and a bone tissue residue, and the acid extract was transferred to a separate container. 3. 0.1 mol / L citrate buffer (pH 3.5) was added to the bone tissue residue. The amount added was 10 mL per gram of initial bone weight. 4. Actinidin (a cysteine protease derived from kiwifruit) was pretreated. Specifically, it was contacted with a 20 mmol / L phosphate buffer (pH 6.5) containing 10 mmol / L dithiothreitol and 5 mmol / L ethylenediaminetetraacetic acid at 25°C for 90 minutes. 5. Activated actinidin was added to the reaction system obtained in step 3 for protease treatment. The treatment conditions were as follows: temperature: 20° C. or 50° C., pH: 3.5 (adjusted with 100 mmol / L phosphate buffer), and time: 3 days.
[0100] The results are shown in Figure 5. In the systems treated with either nitric acid or hydrochloric acid, the bone tissue almost disappeared when the reaction temperature was 50°C.
[0101] The resulting protease-treated solution was passed through a 100 μm filter to remove fine insoluble matter, yielding a filtrate. The results of component analysis of this filtrate are shown in Table 4 (values converted per gram of wet bone weight are shown). The component analysis was outsourced to Kurita Analysis Center Co., Ltd.
[0102]
[0103] [Example 1-7: Preparation of Bone Solubilization Solution A and Component Analysis] Bone solubilization solution A was prepared in one step without solution exchange between acid treatment and protease treatment. The specific procedure is as follows: 1. Bone tissue was immersed in a 1 mol / L aqueous solution of nitric acid, hydrochloric acid, formic acid, or sulfuric acid for 48 hours for acid treatment. 2. Citrate buffer (pH 3.5) was added to the reaction system to a final concentration of 0.1 mol / L. 3. The pH was adjusted to the optimum value for the protease using 5N NaOH and 5N HCl. Specifically, actinidyne was adjusted to pH 3.5, pepsin to pH 3.0, and Neurase F3G to pH 3.0. 4. Each protease was added to a concentration of 1% (w / w). The protease reaction conditions were a temperature of 50°C for 4 days. Actinidain (a cysteine protease derived from kiwi fruit) was pretreated in advance with 20 mmol / L phosphate buffer (pH 6.5) containing 10 mmol / L dithiothreitol and 5 mmol / L ethylenediaminetetraacetic acid at 25°C for 90 minutes.
[0104] The results are shown in Figure 6. In both systems, the bone tissue was reduced in size when the reaction temperature was 50°C. In this way, bone solubilized solution A was obtained from the bone tissue in one step without intervening a solution exchange between the acid treatment and the protease treatment. In particular, the combination of pepsin and hydrochloric acid or nitric acid effectively dissolved the bone tissue, leaving only a small amount of bone tissue remaining.
[0105] The resulting bone solubilized solution A was passed through a 100 μm filter to remove fine insoluble matter, yielding a filtrate. The calcium concentration of this filtrate was measured, and the results are shown in Table 5 (values converted per gram of bone mass are shown). Calcium was measured using a compact calcium ion meter, LAQUAtwin-Ca-11 (Horiba Advanced Techno Co., Ltd.).
[0106]
[0107] [Example 1-8: Extraction of Phosphoric Acid] Crudely purified phosphoric acid was obtained from bone tissue by the following procedure. 1. Bone tissue was immersed in 1 mol / L aqueous nitric acid, hydrochloric acid, formic acid, or sulfuric acid solution for 48 hours for acid treatment. 2. 0.15 volumes of 5N NaOH was added to the reaction system, mixed well, and allowed to stand at room temperature for 1 hour. This resulted in a white solution. 3. The resulting solution was centrifuged at 10,000 g for 10 minutes at room temperature, and the supernatant was removed. 1N HCl was added to the white precipitate in the same amount as added in step 1, and mixed well. This resulted in a clear solution. 4. Na 2 SO 4 , K. 2 SO 4 , MgSO 4 , (NH 4 ) 2 SO 4 , Na 2 CO 3 or NaHCO 3 4. The resulting solution was centrifuged at 10,000 g for 10 minutes at room temperature, and the supernatant was removed. The resulting clear solution contained phosphoric acid.
[0108] By immersing bone tissue in sulfuric acid, a phosphate-containing solution can be obtained from which calcium has been removed to some extent. However, treatment with sulfuric acid increases the volume, makes the solution highly acidic, and contains many impurities, making purification difficult. On the other hand, the above process allows for the easy production of a solution containing highly pure phosphate.
[0109] Example 2: Evaluation of growth and analysis of components of plants grown with fertilizer containing bone tissue decomposition product Materials and methods: 1. Radish (Raphanus sativus L) seeds (Takii Seed Co., Ltd.) were sown on wet paper towels. The seeds were left to germinate in the dark at 22°C for 2 days. 2. The resulting plants were transplanted into urethane cubes (2 cm x 2 cm x 2 cm) for hydroponic cultivation. 3. The urethane cubes were immersed in acid extract, protease treatment solution, or bone solubilization solution A and grown for 5 days. The light conditions during this period were: photosynthetically active photon flux density: approximately 150 μmol / m 2 The light period was 16 hours, with a dark period of 8 hours. A fluorescent lamp for cultivating cultivated plants (Biorux A, NEC Lighting Corporation) was used as the light source. 4. Growth evaluation and component analysis of the grown plants were performed. Specifically, the following procedures were performed: ・Aerial fresh weight: The plant was cut at the boundary between the hypocotyl and the root, and the weight of the hypocotyl side was measured. ・Aerial dry weight: The part of the plant whose fresh weight was measured was dried in an oven at 80°C for two days. The weight was then measured. ・Aerial moisture content: Calculated based on the difference between the aerial fresh weight and the aerial dry weight. ・Leaf area: The cotyledons of the plant were scanned and the leaf area was measured using ImageJ. ・Total polyphenol content: 50 mg of cotyledons were crushed in a 90% methanol solution. The total polyphenol content of the supernatant obtained after centrifugation was measured using the Folin-Ciocalteu method.
[0110] [Results and Discussion] (1) Effect of Acid Extract Concentration on Growth Plants were grown under conditions where acid extract diluted 500-fold or 2000-fold was applied. The results are shown in Figure 7. Plants grown with acid extract diluted 500-fold had an increased aboveground fresh weight compared to control plants. These results demonstrate that acid extract diluted approximately 500-fold has a plant growth-promoting effect. In subsequent experiments, acid extract and protease-treated solution diluted 500-fold were used.
[0111] (2) Effects of Acid Extract, Protease Treatment Solution, or Bone Solubilizing Solution A on Growth Plants were grown under the following six conditions, and the fresh weight of the aboveground parts was compared: - Water only (control) - Unheated protease treatment solution (Protease Treatment Solution 1) - Protease treatment solution heated at 50°C (Protease Treatment Solution 2) - Acid extract - Bone solubilizing solution A, a mixture of Protease Treatment Solution 1 and Acid extract - Bone solubilizing solution A, a mixture of Protease Treatment Solution 2 and Acid extract The results are shown in Figure 8. Plants treated with Protease Treatment Solution 1 and Protease Treatment Solution 2 showed enhanced growth compared to the control. Similarly, plants treated with the acid extract also showed enhanced growth compared to the control (as shown in (1)). Furthermore, plants treated with Bone Solubilizing Solution A, a mixture of Protease Treatment Solution and Acid extract, showed an even greater growth-promoting effect compared to the control. These results demonstrate that both the acid extract and the protease-treated solution have a plant growth-promoting effect. Furthermore, the plant growth-promoting effect of bone solubilization solution A was found to be greater than that of either the acid extract or the protease-treated solution alone.
[0112] (3) Comparison of Effects with Commercially Available Culture Solutions The growth-promoting effects of bone solubilization solution A and a commercially available culture solution were compared. The commercially available culture solution used was a 1 / 6 dilution of Formulation A from OAT House (OAT Agrio Co., Ltd.). This dilution adjusted the nitrate ion concentration to the same level as bone solubilization solution A (approximately 600 ppm).
[0113] The results are shown in Figures 8 and 9. Plants fed with the commercially available culture medium showed growth promotion to the same extent as plants fed with bone solubilizing solution A. Plants fed with both bone solubilizing solution A and the culture medium showed an even greater growth-promoting effect than plants fed with either solution alone. This suggests that bone solubilizing solution A can further improve the growth-promoting effect of the commercially available culture medium.
[0114] The water content of the aboveground parts of the plants increased when bone solubilization solution A was applied, and increased further when both bone solubilization solution A and culture solution were added. The total polyphenol content per cotyledon increased when bone solubilization solution A was applied, and increased further when both bone solubilization solution A and culture solution were applied. This is thought to be due to an increase in cotyledon weight as a result of promoted plant growth.
[0115] Example 3: Plant RNA Expression Analysis 1 Total Plant RNA Extraction 1. Radish (Raphanus sativus L) seeds (Takii Seed Co., Ltd.) were sown on wet paper towels. The seeds were allowed to germinate in the dark at 100% humidity and 22°C for 2 days. 2. The resulting plants were transplanted into urethane sponges. The urethane sponges were impregnated with either (1) water, (2) bone solubilizing solution A, (3) commercially available liquid fertilizer, or (4) a mixture of bone solubilizing solution A and commercially available liquid fertilizer. 3. The plants were grown at 22°C for 1, 3, or 5 days. The light conditions during this period were: light intensity: approximately 100 μmol / m 2 ・s, light period: 16 hours, dark period: 8 hours. Fluorescent lamps for cultivating plants (Biorux A, NEC Lighting Co., Ltd.) were used as the light source. 4. Approximately 0.1 g of leaf and root tissue was collected from the grown plants. Immediately after collection, the tissue was placed in a mortar and liquid nitrogen was added, and the tissue was ground in a frozen state. 5. Total RNA was extracted from the ground tissue using an RNeasy Plant Mini Kit (Qiagen). 6. The concentration of total RNA in the aqueous solution was measured using a Qubit RNA HS Assay Kit (Thermo Fisher Scientific) and a fluorometer (Qubit-4). In addition, the absorbance (A) at 230 nm, 260 nm, and 280 nm was measured. 230 , A 260 and A 280 ) was measured by a spectrophotometer to examine the purity of the extracted RNA.
[0116] The results are shown in Table 6. From the start of culture until the fifth day, 13.2 to 88.2 μg of total RNA was extracted from approximately 0.1 g of plant leaves. From approximately 0.1 g of plant roots, 8.4 to 43.8 μg of total RNA was extracted. 260 / A 280 was about 2.0, confirming that there was no problem with the purity of the RNA.
[0117]
[0118] [Creation of RNA sequence library and RNA sequence analysis using a next-generation sequencer] Creation of a cDNA library from total RNA extracted from sprouts and gene expression analysis using a next-generation sequencer were outsourced to Azenta Co., Ltd. The analysis procedures are as follows: 1. The quality of the extracted total RNA (degree of RNA degradation) was evaluated using a BioAnalyzer (Agilent Technologies). 2. PolyA-mRNA was enriched from the extracted total RNA using beads bound to polyT oligo DNA. 3. A cDNA library was created using reverse transcriptase. 4. The cDNA sequence was determined using a next-generation sequencer (DNBSEQ-G400, MGI Tech). This allowed comprehensive determination of the base sequences of expressed mRNA (RNAseq analysis). Sprout gene assembly was performed using Stringtie software. At this time, we referred to the complete genome sequence of sprouts published in the database of the Kazusa DNA Research Institute, a public interest incorporated foundation (http: / / radish.kazusa.or.jp).
[0119] [Analysis of Genes with Altered Expression Levels] 1. Genes whose expression levels significantly changed due to differences in cultivation conditions were identified based on the FPKM (fragments per kilobase of exon per million reads mapped) value, obtained by correcting the number of reads for each gene by transcript length. DESeq2 software was used for identification. 2. Genes (DEGs) whose expression levels were significantly increased or decreased were comprehensively determined. Analysis results were displayed using a volcano plot. Expression levels were compared between four groups: (1) water only, (2) bone lysate A, (3) commercial liquid fertilizer, and (4) a mixture of bone lysate A and commercial liquid fertilizer. Genes whose expression levels were significantly increased or decreased in groups (2) or (4) were identified. 3. GO enrichment analysis was performed on the identified differentially expressed genes using GOseq software. This allowed for analysis of the biological functions of the differentially expressed genes.
[0120] [Quantitative RT-PCR] Five genes closely related to stress tolerance were used as target genes, and the expression of these genes was examined by quantitative RT-PCR. The target genes used were glutathione S-transferase τ19 (GSTU19), catalase 2 (CAT2), auxin transporter-like protein 2-1 (LAX2-1), glutathione S-transferase 12 (GST12), and calmodulin 5 (CaM5). The specific procedure is as follows: 1. Total RNA was extracted from leaves and roots of plants grown with (1) water, (2) bone lysate A, (3) commercially available liquid fertilizer, or (4) a mixture of bone lysate A and commercially available liquid fertilizer. 2. Reverse transcriptase reaction (RT reaction) was performed using random primers. PrimeScript RT Master Mix (Takara Bio Inc.) was used as the reverse transcriptase. 3. The target gene was subjected to quantitative PCR. For quantitative PCR, a specific primer pair using 2.0 ng of cDNA as a template, TB Green Premix Ex Taq II (Takara Bio Inc.), was used. The quantitative PCR was performed using a Thermal Cycler Dice Real Time System TP850 (Takara Bio Inc.).
[0121] In quantitative RT-PCR, the expression level of each target gene was normalized to that of the actin gene. The base sequences of the primer pairs used to amplify the target genes and actin gene are shown in Table 7 (SEQ ID NOS: 1 to 12, from top to bottom).
[0122]
[0123] Results: Expression levels of the gene encoding glutathione S-transferase τ19 (GSTU-19) were not detected before transplantation onto urethane sponges. Similarly, expression levels were not detected in the leaves and roots of plants grown in a system containing (1) water, (2) bone solubilizer A, or (3) a commercial liquid fertilizer at 1 day after transplantation. However, at 1 day after transplantation, GSTU-19 expression levels were significantly elevated in the leaves and roots of plants grown in a system containing (4) a mixture of bone solubilizer A and a commercial liquid fertilizer (Figure 11). Similarly, at 1 day after transplantation, expression levels of genes encoding catalase 2 (CAT2), auxin transporter-like protein 2-1 (LAX2-1), glutathione S-transferase 12 (GST12), and calmodulin 5 (CaM5) were significantly elevated in the leaves of plants grown in a system containing (4) a mixture of bone solubilizer A and a commercial liquid fertilizer (Figure 12).
[0124] As described above, it was shown that the combined use of a fertilizer according to one embodiment of the present invention and an existing liquid fertilizer promotes the expression of genes involved in plant stress tolerance. This result suggests that the combined use of a fertilizer according to one embodiment of the present invention and an existing liquid fertilizer can improve the stress tolerance of plants.
[0125] Example 4: Improving Phosphate Extraction Rate by Pretreatment We confirmed that pretreatment of bone tissue increases the amount of phosphate contained in the acid extract. Specifically, the acid extract was prepared according to the following procedure, and the amount of phosphate contained therein was quantified. 1. Pork bones obtained from a slaughterhouse were finely ground using a mill (IKA TUBE MILL 100, IKA JAPAN Co., Ltd.). 2. 5 g of the ground pork bones were subjected to one of the following pretreatments (1) to (5): (1) No treatment; (2) Soaking in 30 mL of nitric acid (1 mol / L) at 50°C for 1 day; (3) Irradiation with 500 W microwaves for 30 minutes; (4) Irradiation with 500 W microwaves for 60 minutes; (5) Irradiation with 500 W microwaves for 120 minutes. 3. 30 mL of nitric acid (1 mol / L) was added to the pork bones (1) and (3) to (5). The pork bones (1) to (5) were soaked in 30 mL of nitric acid at 20°C for 48 hours with shaking (100 rpm). In this way, the bone tissue was decalcified. 4. The supernatant was collected and used as the acid extract. 5. The phosphate concentration was measured using a Malachite Green Phosphate Assay Kit (BioAssay Systems). The measurement method followed the instructions provided with the product. For the measurement, the supernatant was diluted with distilled water.
[0126] [Results] The results are shown in Figure 13. From bone tissue (2) pretreated by heating at 50°C, 1.18 times more phosphoric acid was extracted than from bone tissue (1) that was not pretreated. Furthermore, from bone tissues (3) to (5) pretreated by microwave irradiation, up to 1.26 times more phosphoric acid was extracted than from bone tissue (1) that was not pretreated.
[0127] Thus, it was found that the amount of phosphate extracted into the acid extract solution can be increased by performing an appropriate pretreatment. In particular, microwave irradiation is a preferred embodiment because it can be completed in a short time, does not require heating, can be applied to large bone tissues, and can further improve the extraction rate of phosphate.
[0128] Example 5: Analysis of Protein Components in Acid Extract The protein components in the acid extract were analyzed using the following procedure. 1. Pork bones obtained from a slaughterhouse were finely pulverized using a mill (IKA TUBE MILL 100, IKA JAPAN Co., Ltd.). 2. 30 mL of hydrochloric acid (1 mol / L) was added to 2 g of wet pork bones, and the bones were immersed at 20°C for 48 hours with shaking (100 rpm). In this way, the bone tissue was decalcified. 4. The supernatant was collected and used as the acid extract. 5. The resulting acid extracts were named (1) stock acid extract, (2) 1 / 2 diluted acid extract, and (3) 1 / 4 diluted acid extract, respectively. 6. An appropriate amount of 1 mol / L NaOH solution was added to neutralize the pH. 5. An equal amount of dithiothreitol was added as a reducing agent, and the mixture was heated at 95°C for 10 minutes. 6. Electrophoresis was carried out by a conventional method using a 5% polyacrylamide gel (for high molecular weight components) and a 12.5% polyacrylamide gel (for low molecular weight components).
[0129] [Results] The results are shown in Figure 14. As a control sample, type I collagen, a protein found in large quantities in bone, and a molecular weight marker were electrophoresed on the same gel. As can be seen from the figure, no proteins with a molecular weight of 10,000 Da or more, which can be stained with a highly sensitive silver staining kit, were detected in the acid extract. In other words, it was found that the acid extract contained almost no protein components. This is thought to be because the peptide bonds of the proteins were cleaved to form low-molecular-weight peptides and amino acids when treated with hydrochloric acid, a strong acid.
[0130] Example 6: Preparation of protease-treated solution and analysis of protein components Example 6-1: Preparation of protease-treated solution A protease-treated solution was obtained according to the following procedure. 1. Bone tissue was immersed in a 1 mol / L aqueous hydrochloric acid solution for 48 hours for acid treatment. 2. The obtained treatment solution was separated into an acid extract and a bone tissue residue, and the acid extract was transferred to a separate container. 3. 0.1 mol / L citrate buffer (pH 3.5) was added to the bone tissue residue. The amount added was 10 mL per gram of initial bone weight. 4. The obtained bone tissue residue was immersed in a treatment solution containing the following three types of proteases. The protease treatment conditions were a protease concentration of 2% (w / w), a temperature of 50°C, and an optimal pH.・Proleather FG-F (Amano Enzyme Co., Ltd., derived from Bacillus sp.) ・Protease P "Amano" 3G (Amano Enzyme Co., Ltd., derived from Aspergillus melleus) ・Protease M "Amano" SD (Amano Enzyme Co., Ltd., derived from Aspergillus oryzae)
[0131] [Results] The appearance of the treated solution is shown in Figure 15. For reference, the results of Example 1-5 (Nurase F3G and pepsin) and Example 1-6 (Actinidyne) are also shown. As can be seen from the figure, it was found that the proteases examined in this example were also able to decompose bone decomposition residue, resulting in a protease-treated solution. Note that precipitates were observed in the protease-treated solution obtained in this example, but this is thought to be calcium salt precipitation resulting from the liquid's near-neutral pH. Taking into account the results of Example 6-2 described below, it can be said that the proteins contained in the bone decomposition residue were sufficiently decomposed by the protease treatment.
[0132] Example 6-2: Analysis of protein components contained in protease-treated solution In the same manner as in Examples 1-5, 1-6, and 6-1, a protease-treated solution was prepared using the following proteases: Pepsin (Sigma Aldrich, aspartic acid protease) Peptidase R (Amano Enzyme Inc., derived from the genus Rhizopus) Protease P "Amano" 3G (Amano Enzyme Inc., derived from Aspergillus melleus) Proleather FG-F (Amano Enzyme Inc., derived from Bacillus sp.) Neurase F3G (Amano Enzyme Inc., derived from Rhizopus niveus) Protease M "Amano" SD (Amano Enzyme Inc., derived from Aspergillus oryzae) Actinidain (derived from kiwifruit, cysteine protease)
[0133] The resulting protease-treated solution was diluted 10-fold (lane A) or 5-fold (lane B) and subjected to electrophoresis on a 16% polyacrylamide gel. The electrophoresed proteins were silver stained. As a control sample, a solution containing only the enzyme (lane C) was also electrophoresed.
[0134] The results are shown in Figure 16. As shown in the figure, all of the protease-treated solutions contained protein components with molecular weights different from those of the enzyme (lane C). In other words, regardless of the protease used, the proteins contained in the bone tissue residue were decomposed. The peptides decomposed in this way are used by the plant body as a nutrient source.
[0135] Example 7: Recovery of Phosphoric Acid from Bone Tissue Phosphoric acid was recovered as a precipitate from the acid extract using the following procedure. The recovery rate of phosphoric acid was also calculated. 1. Pork bones obtained from a slaughterhouse were finely pulverized using a mill (IKA TUBE MILL 100, IKA JAPAN Co., Ltd.). 2. The pulverized pork bones were immersed in 1N aqueous nitric acid or 1N aqueous hydrochloric acid for 48 hours. 3. The supernatant was collected to obtain the acid extract. 4. 30 μL, 50 μL, 70 μL, 100 μL, or 120 μL of 5N aqueous sodium hydroxide was added to 0.5 mL of the acid extract and allowed to stand at room temperature for 1 hour. This allowed the phosphoric acid to precipitate. 5. The reaction solution was separated into the supernatant and precipitate by centrifugation. 6. 0.5 mL of 1N aqueous hydrochloric acid was added to the precipitate to redissolve the phosphoric acid. 7. The phosphate content was measured in the precipitate redissolution solution obtained in step 5 and the supernatant obtained in step 4. A Malachite Green Phosphate Assay Kit (BioAssay Systems) was used for the measurements. The phosphate recovery rate was calculated based on the phosphate content in the acid extract obtained in step 3.
[0136]
[0137] [Results] The results are shown in Table 8. In the acid extract using nitric acid, if the amount of NaOH aqueous solution added was 100 μL or more, 70% or more of the phosphoric acid could be recovered as a precipitate. On the other hand, if the amount of NaOH aqueous solution added was 120 μL, the phosphoric acid contained in the supernatant was reduced to about 10%. In the acid extract using hydrochloric acid, if the amount of NaOH aqueous solution added was 70 μL or more, 70% or more of the phosphoric acid could be recovered as a precipitate. On the other hand, if the amount of NaOH aqueous solution added was 100 μL, the phosphoric acid contained in the supernatant was reduced to about 10%. Thus, by adding an appropriate amount of NaOH aqueous solution to the acid extract, phosphoric acid could be recovered and roughly purified as a precipitate.
[0138] Incidentally, the phosphoric acid content in the acid extract using nitric acid was 24.6 mg. This corresponds to 34.7% of the wet weight (71 mg) of the pork bones used in step 2. The phosphoric acid content in the acid extract using hydrochloric acid was 15.1 mg. This corresponds to 20.2% of the wet weight (74.5 mg) of the pork bones used in step 2. Since the weight of phosphoric acid in bone tissue before drying is considered to be 25-35%, this means that up to 99% (= 34.7 / 35 × 100) of the phosphoric acid can be extracted by preparing the acid extract.
[0139] Example 8: Purification of Phosphoric Acid by Addition of Sulfate Example 8-1: Investigation of Phosphoric Acid Recovery Rate in Supernatant Calcium was removed as calcium sulfate precipitate from the redissolved solution of phosphoric acid precipitate obtained in Example 7 by the following procedure. 1. A redissolved solution of phosphoric acid precipitate was prepared in the same manner as in Example 7. The acid used in Step 2 of Example 7 was a 1N aqueous solution of nitric acid or a 1N aqueous solution of hydrochloric acid. The amount of 5N aqueous sodium hydroxide added in Step 4 of Example 7 was 100 μL. 2. Sulfuric acid or a sulfate salt (sodium sulfate, potassium sulfate, ammonium sulfate, or magnesium sulfate) was added. The amount of sulfuric acid or sulfate salt added was such that the final concentration was 0.4 M, 0.6 M, 0.8 M, or 1.0 M. 3. The resulting calcium sulfate precipitate was removed by centrifugation. 4. The weight of phosphoric acid contained in the supernatant was measured. The Malachite Green Phosphate Assay Kit (BioAssay Systems) was used for the measurement. The phosphoric acid recovery rate was calculated based on the phosphoric acid content in the precipitate formed by adding an aqueous sodium hydroxide solution to the acid extract (the precipitate obtained in step 5 of Example 7) before adding sulfuric acid or sulfate.
[0140]
[0141] [Results] The results are shown in Table 9. It was found that, if the sulfate concentration is appropriately set, a phosphate recovery rate comparable to that of sulfuric acid can be achieved with sulfate. Furthermore, at a low concentration of 0.4 M, the phosphate concentration obtained by adding sulfate tended to be slightly higher than that obtained by adding sulfuric acid. Importantly, the addition of sulfate not only reduces the volume of the system compared to the addition of sulfuric acid, but also results in a phosphate concentration that is approximately 1.5 times higher. In this respect, the method according to one embodiment of the present invention is a useful method for purifying phosphoric acid. Furthermore, when putting the technology into practical use, it is preferable to add less sulfuric acid or sulfate, further demonstrating the effectiveness of the calcium removal effect of sulfate.
[0142] The use of sulfates instead of sulfuric acid for calcium precipitation has the following advantages: - The phosphoric acid concentration is about 1.5 times higher. - Because no liquid is added, the increase in the volume of the reaction system can be reduced. - Because the reaction system does not become strongly acidic, only a small amount of base is required for neutralization. - High safety.
[0143] Example 8-2: Examination of calcium removal ability from supernatant The calcium content in the supernatant obtained in step 4 of Example 8-1 was measured. LAQUAtwin-Ca-11 was used for the measurement. The calcium residual rate was calculated based on the calcium content in the precipitate formed by adding an aqueous sodium hydroxide solution to the acid extract (the precipitate obtained in step 5 of Example 7) before adding sulfuric acid or sulfate.
[0144]
[0145] [Results] The results are shown in Table 10. When compared at the same concentration, sulfate generally had a lower calcium retention rate than sulfuric acid. For example, in an experimental system where 0.4 M sodium hydroxide was added after acid treatment with hydrochloric acid, the amount of calcium in the solution was 100%. 2 SO 4The calcium removal capacity of the sulfate salt was 1,210 μg, while that of the sulfate salt was 155-270 μg. In other words, under these conditions, the calcium removal capacity of the sulfate salt was up to 7.8 times higher. Importantly, when comparing the solution with sulfate salt and the solution with sulfuric acid salt, the calcium concentration of the former was reduced to about half that of the latter, even though the solution volume of the former was about half that of the latter. In other words, by adding sulfate salt, calcium unnecessary for purifying phosphoric acid can be efficiently removed.
[0146] When comparing the acids used in the acid treatment, the calcium residue rate was lower in the treatment with hydrochloric acid than in the treatment with nitric acid. The system that was most successful in removing calcium was the system in which 1M potassium sulfate was added to the acid extract treated with hydrochloric acid.
[0147] Table 11 shows the relative ratio (%) of calcium (mg) to phosphate (mg) calculated based on the results of Tables 9 and 10. Phosphate can also be recovered by adding sulfuric acid, but the residual calcium level was greater in all concentrations than in the experimental system where sulfate was added. On the other hand, when phosphate was recovered by adding sulfate, the residual calcium level was significantly lower than in the experimental system where sulfuric acid was added, and the recovered amount of phosphate was relatively high. Thus, by adding an appropriate amount of sulfate, the residual calcium level can be reduced to 0.2 wt % without reducing the recovered amount of phosphate. Therefore, it can be said that using sulfate is preferable to sulfuric acid for purifying phosphate extracted from bone tissue.
[0148] Example 8-3: Study of Phosphate Loss Rate in Precipitate The phosphate content in the calcium sulfate precipitate obtained in step 3 of Example 8-1 was measured according to the following procedure. 1. EDTA (pH 7.4) and 5N sodium hydroxide were added to the calcium sulfate precipitate to redissolve it. 2. The phosphate content in the resulting solution was measured. For the measurement, a Malachite Green Phosphate Assay Kit (BioAssay Systems) was used. The phosphate loss rate was calculated based on the phosphate content in the precipitate (precipitate obtained in step 5 of Example 7) formed by adding aqueous sodium hydroxide to the acid extract before adding sulfuric acid or sulfate.
[0149]
[0150] [Results] The results are shown in Table 12. As can be seen from the table, by appropriately adjusting the sulfate concentration, the phosphate content in the calcium sulfate precipitate could be reduced to the same level as that of sulfuric acid. A sulfate concentration of 0.4 M was sufficient to reduce the amount of phosphate that leaked out.
[0151] [Example 8-4: Study of total phosphoric acid recovery rate] The sum of the phosphoric acid recovery rate in the supernatant studied in Example 8-1 and the phosphoric acid loss rate into the precipitate studied in Example 8-3 was studied. The phosphoric acid contained in the precipitate is likely to be re-recovered by washing the precipitate. For example, by washing the precipitate (calcium sulfate) with pure water, the phosphoric acid contained in the precipitate can be recovered. Therefore, the higher the total phosphoric acid content, the greater the potential amount of phosphoric acid that can be recovered.
[0152]
[0153] [Results] The results are shown in Table 13. It was found that by adjusting the concentration appropriately, it is possible to achieve a phosphate recovery rate comparable to that of sulfuric acid using sulfate. Although the total recovery rate was higher in the acid extract using hydrochloric acid, the absolute phosphate content was similar between the acid extract using hydrochloric acid and the acid extract using nitric acid.
[0154] [Example 9: Plant RNA expression analysis 2] [Preparation of cDNA library and gene expression analysis using next-generation sequencer] The same procedures as in Example 3 were used.
[0155] [Analysis of genes with altered expression levels] This was carried out using the same procedure as in Example 3. Comparison of expression levels was carried out between two pairs of conditions: bone solubilization solution B vs. commercially available liquid fertilizer, and a mixture of bone solubilization solution B and commercially available liquid fertilizer vs. commercially available liquid fertilizer alone.
[0156] [Results] Figure 18 shows the results of an analysis of genes with altered expression in leaves of sprouts grown for five days with bone lysate B or commercially available liquid fertilizer. There were 1,568 genes whose FPKM values increased by more than two-fold. There were 1,654 genes whose FPKM values decreased by half or less. Therefore, the expression levels of a total of 3,222 genes were altered. GO enrichment analysis revealed that the genes with altered expression levels included 65 genes related to growth control, 44 genes related to photosynthesis, and 26 genes involved in light harvesting in photosystem I of photosynthesis.
[0157] Figure 19 shows the results of an analysis of genes with altered expression in the roots of sprouts grown for five days with a mixture of bone solubilization solution B and commercially available liquid fertilizer, or with commercially available liquid fertilizer alone. 766 genes showed a two-fold or greater increase in FPKM value. 1,235 genes showed a half-fold or greater decrease in FPKM value. Therefore, a total of 2,001 genes showed altered expression levels. GO enrichment analysis revealed that the genes with altered expression levels included 17 genes related to nitrate assimilation, 16 genes related to root hair elongation, and 12 genes related to nitrate uptake.
[0158] Figure 20 shows the results of an analysis of differentially expressed genes in the leaves of sprouts grown for five days with a mixture of bone solubilization solution B and commercial liquid fertilizer, or with commercial liquid fertilizer alone. There were 582 genes whose FPKM values increased by more than two-fold. There were 662 genes whose FPKM values decreased by half or less. Therefore, the expression levels of a total of 1,244 genes were altered. GO enrichment analysis revealed that the genes whose expression levels were altered included 32 genes related to the response to abscisic acid (a plant hormone), 13 genes related to root hair elongation, and 6 genes related to the promotion of germination.
[0159] 18 to 20 show that bone lysate B alters gene expression in sprouts. In particular, the expression of genes related to leaf or root tissue growth, photosynthesis in leaves, and nutrient absorption in roots was significantly altered.
[0160] Example 10: Study on calcium ion removal efficiency by adding sulfate By adding sulfate to the solution of redissolving phosphate precipitate, calcium ions were removed as calcium carbonate precipitate. The calcium ion content in the supernatant after precipitate removal was measured to study the calcium removal efficiency. The specific procedures are as follows: 1. A solution of redissolving phosphate precipitate was prepared in the same manner as in Example 7. The acid used in step 2 of Example 7 was a 1N aqueous solution of hydrochloric acid. The amount of 5N aqueous solution of sodium hydroxide added in step 4 of Example 7 was 100 μL. 2. Liquid sulfuric acid (H 2 SO 4 ) or solid sulfate (Na 2 SO 4 , K. 2 SO 4 , Mg 2 SO 4 and (NH 4 ) 2 SO 4) was added. The amount of sulfuric acid or sulfate added was adjusted to a final concentration of 0.4 M. 3. The resulting calcium sulfate precipitate was removed by centrifugation. 4. The weight (mg) of calcium ions contained in the supernatant was measured. Calcium ion measurement was performed under precise measurement conditions using a high-performance ion chromatograph IC-8100EX (Tosoh Corporation) connected to a TSKgel SuperIC-Cation HSII (4.6 mm ID x 10 cm). A mixture of 3.0 mmol / L metasulfonic acid and 2.7 mmol / L 18-crown-6 was used as the eluent. The measurement temperature was 40°C, the flow rate was 1.0 mL / min, and the injection volume was 30 μL. The calcium ion concentration was determined by measuring the electrical conductivity (μS) and calculating a regression equation from the area of the standard substance. The calcium ion content per sample (30 μL) was calculated from the calcium ion concentration.
[0161]
[0162] [Results] The results are shown in Table 14. In the system to which liquid sulfuric acid was added, not only did the volume of the entire system increase, but the calcium ion removal rate was also the lowest at 73%. In the system to which solid sulfate was added, the increase in the volume of the entire system was small, and the calcium ion removal rate was high at 91-94%. In addition, since sulfuric acid, a strong acid, is not used, the method of adding sulfate is also highly safe. Furthermore, by appropriately increasing or decreasing the amount of sulfate added, it was possible to retain calcium at the desired concentration.
[0163] When producing phosphoric acid or phosphate-containing fertilizer from bone tissue, calcium ions contained in bone tissue contribute to reducing the recovery of phosphate. This is because, in the neutral range, calcium ions combine with phosphate ions to form calcium phosphate precipitates. Therefore, it is desirable to remove calcium ions by precipitation, and it has been shown that this can be successfully achieved by adding sulfate.
[0164] The potassium ions, magnesium ions, or ammonium ions contained in sulfates are components necessary for plant growth. Therefore, by using potassium sulfate, magnesium sulfate, or ammonium sulfate as the sulfate, the components necessary for plant growth can be contained in the fertilizer. Alternatively, by changing the base added in step 4 of Example 7 from sodium hydroxide to potassium hydroxide, the components necessary for plant growth can also be contained in the fertilizer. By employing such a production method, a fertilizer with increased value can be produced.
[0165] Example 11: Purification of Phosphoric Acid by Addition of Carbonate Calcium was removed as calcium carbonate precipitate from the redissolved solution of phosphoric acid precipitate obtained in Example 7 by the following procedure. 1. A redissolved solution of phosphoric acid precipitate was prepared in the same manner as in Example 7. The acid used in Step 1 of Example 7 was a 1N aqueous solution of nitric acid or a 1N aqueous solution of hydrochloric acid. The amount of 5N aqueous sodium hydroxide added in Step 4 of Example 7 was 100 μL. 2. Carbonate (solid sodium bicarbonate or sodium carbonate) was added. The amount of sodium bicarbonate added was such that the final concentration was 0.4 M. The amount of sodium carbonate added was such that the final concentration was 0.6 M. 3. The resulting calcium carbonate precipitate was removed by centrifugation. 4. The concentration (ppm) of phosphate ions contained in the supernatant was measured. Phosphate ion measurements were performed under precise measurement conditions using a high-performance ion chromatograph IC-8100EX (Tosoh Corporation) connected to a TSKgel Super IC-Anion HS (4.6 mm ID x 10 cm). A mixture of 7.5 mmol / L sodium bicarbonate and 0.8 mmol / L sodium carbonate was used as the eluent. The measurement temperature was 40°C, the flow rate was 1.5 mL / min, and the injection volume was 30 μL. The electrical conductivity (μS) was measured, and the phosphate ion concentration was determined by calculating a regression equation from the area of the standard substance. The phosphate ion content per sample (30 μL) was calculated from the phosphate ion concentration.
[0166]
[0167] [Results] The results are shown in Table 15. By adding carbonate, calcium ions precipitated as calcium carbonate, and phosphate ions remained in the supernatant. For example, in a system in which sodium bicarbonate was added to the acid extract with hydrochloric acid, more than 9,000 ppm of phosphate was contained in the supernatant. Carbonate ions remaining in the supernatant were converted to carbon dioxide when heated and could be easily removed.
[0168] Example 12: Removal of Cations Contained in Sulfate Example 12-1: Removal of Sodium or Potassium Ions Cations (sodium or potassium ions) contained in sulfate added to remove calcium ions were removed using the following procedure. Specifically, sodium or potassium ions were adsorbed using a strong cation exchange gel. 1. TSKgel SP-TOYOPEARL 650M gel (Tosoh Corporation) was decanted with purified water and packed into a microspin column (GE Healthcare). 2. An appropriate amount of the supernatant obtained after adding sulfate to remove calcium sulfate was added to the upper layer of the gel. 3. The supernatant was passed through the gel by centrifugation in a tabletop centrifuge. The flow-through fraction was collected. 3. The content (mg) of sodium or potassium ions contained in the flow-through fraction was measured. Sodium ions were measured using LAQUAtwin-Na-11 (Horiba Advanced Techno Co., Ltd.), and potassium ions were measured using LAQUAtwin-K-11 (Horiba Advanced Techno Co., Ltd.).
[0169]
[0170] [Results] The results are shown in Table 16. The supernatant obtained after precipitating calcium sulfate by adding sodium sulfate or potassium sulfate contains sodium ions or potassium ions. These ions could be removed by passing the solution through a strong cation exchange gel. Specifically, 83% of the sodium ions were removed, and 86% of the potassium ions were removed. Repeated passage through the strong cation exchange gel allowed even more cations to be removed.
[0171] Thus, it was shown that the cations added as sulfate in the sulfate addition method can be removed using a strong cation exchange gel. However, when producing fertilizer from bone tissue, potassium ions, magnesium ions, and ammonium ions do not need to be removed because they are important nutritional elements for plant growth.
[0172] Example 12-2: Removal of Magnesium Ions or Ammonium Ions Cations (magnesium ions or ammonium ions) contained in sulfate added to remove calcium ions were removed using the following procedure. Specifically, magnesium ions or ammonium ions were adsorbed using a strong cation exchange gel. 1. TSKgel SP-TOYOPEARL 650M gel (Tosoh Corporation) was decanted with purified water and packed into a microspin column (GE Healthcare). 2. An appropriate amount of the supernatant obtained after adding sulfate to remove calcium sulfate was added to the upper layer of the gel. 3. The supernatant was passed through the gel by centrifugation in a tabletop centrifuge. The flow-through fraction was collected. 3. The content (μg) of magnesium ions, ammonium ions, or calcium ions contained in the flow-through fraction was measured. Ion concentration measurements were performed under precise measurement conditions using a high-performance ion chromatograph IC-8100EX (Tosoh Corporation) connected to a TSKgel SuperIC-Cation HSII (4.6 mm ID x 10 cm). A mixture of 3.0 mmol / L methanesulfonic acid and 2.7 mmol / L 18-crown-6 was used as the eluent. The measurement temperature was 40°C, the flow rate was 1.0 mL / min, and the injection volume was 30 μL. The calcium ion concentration was determined by measuring the electrical conductivity (μS) and calculating a regression equation from the area of the standard substance. The ion content per sample (30 μL) was calculated from the ion concentration.
[0173]
[0174] [Results] The results are shown in Table 17. It was shown that magnesium ions, ammonium ions, and calcium ions could also be removed from the supernatant by contacting it with a strong cation exchange gel. By repeatedly passing the solution through the strong cation exchange gel, even more cations, including calcium ions, could be removed. This suggests that the purity of the phosphoric acid could be increased.
[0175] Example 13: Purification of Phosphoric Acid from Commercially Available Bone Powder Commercially available steamed bone powder (Omiya Green Service Co., Ltd.) was solubilized and phosphoric acid was recovered according to the following procedure. 1. 10 mL of 1N sulfuric acid, 1N hydrochloric acid, or 1N nitric acid was added to 1 g of steamed bone powder and shaken at 25°C for 19 hours. 2. The resulting acid extract was separated into a supernatant and a precipitate using a centrifuge. 3. 0.1 mL of 5N NaOH aqueous solution was added to 0.5 mL of the supernatant and shaken for 1 hour. 4. The reaction solution was separated into a supernatant and a precipitate by centrifugation. 5. An appropriate amount of 1N hydrochloric acid was added to the precipitate to dissolve it. 6. Steps 3 to 5 were repeated multiple times. The precipitate was then dissolved in 0.5 mL of 0.4N hydrochloric acid. This yielded a precipitate solution with concentrated phosphoric acid. 7. The anion content in the resulting precipitate solution was measured. Measurements were performed under precise measurement conditions using a high-performance ion chromatograph IC-8100EX (Tosoh Corporation) connected to a TSKgel Super IC-Anion HS (4.6 mm ID x 10 cm). A mixture of 7.5 mmol / L sodium bicarbonate and 0.8 mmol / L sodium carbonate was used as the eluent. The measurement temperature was 40°C, the flow rate was 1.5 mL / min, and the injection volume was 30 μL. The electroconductivity (μS) was measured, and the anion ion concentration was determined by calculating a regression equation from the area of the standard substance. The anion ion content per sample (30 μL) was calculated from the anion ion concentration.
[0176]
[0177] [Results] The results are shown in Table 18 and Figure 21. Even when commercially available steamed bone powder (bone tissue heat-treated under high pressure) was used as the raw material, phosphoric acid could be recovered efficiently and relatively safely by the phosphoric acid production method according to one embodiment of the present invention. According to Table 18, the phosphoric acid recovery efficiency was higher when using an acid extract with hydrochloric acid or nitric acid than when using an acid extract with sulfuric acid. The phosphoric acid recovery efficiency of the system using hydrochloric acid or nitric acid was 3.2 to 3.4 times that of the system using sulfuric acid.
[0178] This is also shown in Figure 21. According to the ion chromatography elution curve shown in the figure, in the systems using hydrochloric acid or nitric acid, almost no anions other than phosphate ions were contained except for chloride ions (hydrochloric acid was used to dissolve the precipitate in step 5). On the other hand, in the system using sulfuric acid, sulfate ions were detected in addition to phosphate ions.
[0179] The results of this example demonstrate that phosphoric acid can be extracted from commercially available bone meal (bone tissue heat-treated under pressure), demonstrating that the method for producing phosphoric acid according to one embodiment of the present invention is a sustainable technology with lower energy costs and less environmental damage than methods for recovering phosphoric acid from phosphate rock or dried sewage sludge.
[0180] Example 14: Preparation of protease-treated solution from commercially available bone powder. Commercially available steamed bone powder (Omiya Green Service Co., Ltd.) was solubilized to prepare a protease-treated solution according to the following procedure. 1. 10 mL of 1N sulfuric acid, 1N hydrochloric acid, or 1N nitric acid was added to 1 g of steamed bone powder and shaken at 25°C for 24 hours. 2. The resulting acid extract was separated into a supernatant (acid extract) and a precipitate (bone residue) using a centrifuge. 3. 10 mL of 0.1 mol / L citrate buffer (pH 3) or 0.1 mol / L Tris-HCl buffer (pH 8) was added to the precipitate. 4. A protease-treated solution was prepared from the precipitate according to S5 in Figure 1. The protease used was Neurase F3G (Amano Enzyme Inc.) or Papain W-40 (Amano Enzyme Inc.), and the treatment was carried out using the same procedures as in Examples 1-5. Specifically, the procedures were as follows: Neurase F3G system: protease concentration = 1% (w / w) of the initial bone weight, buffer = citrate buffer (pH 3), temperature = 37°C, soaking time = 3 days Papain W-40 system: protease concentration = 1% (w / w) of the initial bone weight, buffer = Tris-HCl buffer (pH 8), temperature = 37°C, soaking time = 3 days 5. The reaction solution was centrifuged to separate the precipitate and the supernatant.
[0181] [Results] The results are shown in Figures 22 and 23. Commercially available steamed bone meal is a mixture of pork bones and chicken bones that have been heat-treated under high pressure. Using this bone meal as a raw material, a protease-treated solution could be prepared by the fertilizer manufacturing method according to one embodiment of the present invention. The protease-treated solution can be used as a fertilizer itself, or it can be used as a raw material for bone solubilization solution B. Liquid fertilizer is expected to have an immediate plant growth effect that cannot be expected from solid bone meal. Liquid fertilizer can also be used for hydroponic cultivation and foliar spraying.
[0182] Regarding protease treatment using Neurase F3G, the bone residue after acid treatment with hydrochloric acid was almost completely dissolved by the protease treatment. The bone residue after acid treatment with nitric acid was also completely dissolved by the protease treatment. The bone residue after acid treatment with sulfuric acid still showed a white precipitate after protease treatment. This precipitate was thought to be calcium sulfate, and it is believed that at least a portion of the protein components had been decomposed.
[0183] Regarding protease treatment using papain W-40, the bone residues after acid treatment with hydrochloric acid or nitric acid were almost completely dissolved by the protease treatment. The bone residues after acid treatment with sulfuric acid also showed a white precipitate after protease treatment. This precipitate was thought to be calcium sulfate, and it is believed that at least a portion of the protein components had been decomposed.
[0184] These results demonstrate that when preparing a protease-treated solution using an acid extract prepared using sulfuric acid as a starting material, it may be necessary to remove precipitates by centrifugation or other methods. When preparing a protease-treated solution using an acid extract prepared using hydrochloric acid or nitric acid as a starting material, it is not necessary to remove precipitates. In this respect, it is preferable to use hydrochloric acid or nitric acid in the acid treatment step. Furthermore, the centrifuged supernatant of the solution after protease treatment was clear when treated with sulfuric acid, but cloudy when treated with nitric acid or hydrochloric acid. These results demonstrate that acid treatment with hydrochloric acid or nitric acid is more preferable for more complete decomposition of bone residues. However, it should be noted that a protease-treated solution can also be prepared using sulfuric acid.
[0185] Example 15: Measurement of Peptide Concentration in Acid Extract Prepared from Commercially Available Bone Powder. An acid extract was prepared from commercially available steamed bone powder (Omiya Green Service Co., Ltd.) using the following procedure. The peptide concentration in the acid extract was measured. 1. 10 mL of 1N sulfuric acid, 1N hydrochloric acid, or 1N nitric acid was added to 1 g of steamed bone powder and shaken at 25°C for 24 hours. 2. The resulting acid extract was separated into a supernatant and a precipitate using a centrifuge. The supernatant was collected as the acid extract. 3. 0.4 mol / L aqueous potassium hydroxide solution was added to 0.5 mL of the supernatant to precipitate the dispersed calcium. 4. The peptide concentration in the supernatant obtained in step 3, after removing the precipitate, was measured. A Protein Assay BCA Kit (product number 297-73101, Fujifilm Wako) was used for the measurement. The measurement method was as described in the product manual. The absorbance at 540 nm was measured. The higher the absorbance, the higher the peptide concentration. 5. The precipitate was recovered from the reaction solution obtained in step 3. Only the system treated with hydrochloric acid or nitric acid in step 1 was recovered. 6. The precipitate was completely dissolved with 1 N hydrochloric acid. 0.4 mol / L potassium hydroxide was then added again to precipitate calcium phosphate. This dissolution-precipitation process was repeated three times. 7. In step 6, after the first and third repetitions were completed, the peptide concentration in the supernatant from which the precipitate was removed was measured. A Protein Assay BCA Kit (product number 297-73101, Fujifilm Wako) was used for the measurement. The measurement method was according to the product manual. The absorbance at 540 nm was measured. The higher the absorbance, the higher the peptide concentration.
[0186]
[0187] [Results] The results are shown in Table 19. Peptides were detected in the acid extract prepared using commercially available steamed bone meal as the raw material. The peptide concentration was highest in the acid extract treated with hydrochloric acid, followed by the acid extract treated with sulfuric acid and finally the acid extract treated with nitric acid. These results indicated that the acid extract treated with hydrochloric acid in particular contained a large amount of peptides. Peptides are organic components contained in bone tissue. This suggests that the acid extract contains components that have a plant growth promoting effect.
[0188] In Example 5, it was shown that the acid extract contained almost no protein components that could be stained with a silver staining kit (see also FIG. 14). The reason for this was assumed in Example 5 to be that the peptide bonds of the proteins were cleaved to form low-molecular-weight peptides and amino acids. This example supports this assumption.
[0189] Peptides become impurities in the production of phosphoric acid. It was found that peptide impurities could be almost completely removed by repeating the calcium phosphate dissolution-precipitation process (steps S13 and S14 in Figure 3). As shown in Table 19, the peptide concentration was reduced to 1 / 100 by repeating the dissolution-precipitation process three times. This result suggests that peptides can be successfully removed and the phosphoric acid concentration increased, particularly from acid extracts treated with hydrochloric acid or nitric acid.
[0190] The present invention can be used for growing plants, etc.
Claims
1. A method for producing a fertilizer containing phosphoric acid, comprising the following step 1: Step 1: A step of treating bone tissue with a solution containing both an acid and a protease and producing a fertilizer from the resulting bone lysate A.
2. A method for producing a fertilizer containing phosphoric acid, comprising the following step 2: Step 2: A step of treating the bone tissue with acid and producing fertilizer from the resulting acid extract. The method further comprises one or more of the following steps (i) and (ii): (i) a pretreatment step of irradiating microwaves to the bone tissue prior to the step 2; (ii) adding potassium, magnesium and / or ammonium sulfates, carbonates and / or bicarbonates to the acid extract after step 2.
3. A method for producing a fertilizer containing phosphoric acid, comprising the following step 3: Step 3: A step of treating the acid-treated bone tissue with a protease and producing a fertilizer from the resulting protease-treated liquid.
4. A method for producing a fertilizer containing phosphoric acid, comprising the following steps 2, 3 and 4: Step 2: A step of treating the bone tissue with acid and producing fertilizer from the resulting acid extract. Step 3: A step of treating the acid-treated bone tissue with a protease and producing a fertilizer from the resulting protease-treated liquid. Step 4: A step of mixing the acid extract and the protease-treated solution to produce fertilizer from the obtained bone solubilized solution B.
5. The method according to any one of claims 1 to 4, wherein the acid includes at least one selected from the group consisting of nitric acid, hydrochloric acid, formic acid, and sulfuric acid.
6. The method according to any one of claims 1, 3 and 4, wherein the protease includes a protease having an optimum pH of 1.5 to 8.
0.
7. The method according to any one of claims 1 to 4, which satisfies the following (i) or (ii): (i) Treating the bone tissue with a solution containing both an acid and a protease at 5-60°C. (ii) The bone tissue is subjected to an acid treatment at 5 to 60°C.
8. The method according to any one of claims 1 to 4, which satisfies the following (i) or (ii): (i) Treating the bone tissue with a solution containing 0.6 to 2.0 mol / L of an acid, the solution containing both an acid and a protease. (ii) The bone tissue is treated with an acid of 0.6 to 2.0 mol / L.
9. The method according to any one of claims 1 to 4, which satisfies the following (i) or (ii): (i) Treating the bone tissue with a solution containing both an acid and a protease for 6 to 48 hours. (ii) The bone tissue is subjected to an acid treatment for 6 to 48 hours.
10. The method further comprises the step of pretreating the bone tissue, The pretreatment step is carried out before treating the bone tissue with a solution containing both an acid and a protease or before treating the bone tissue with an acid; 5. The method according to claim 1, 3 or 4, wherein the pretreatment is one or more selected from the group consisting of heating the bone tissue, heating the bone tissue under pressure, and irradiating the bone tissue with microwaves.
11. The method according to claim 10, wherein the pretreatment step denatures proteins contained in the bone tissue.
12. A fertilizer obtained by the method according to any one of claims 1 to 4.
13. The fertilizer of claim 12 which is a liquid fertilizer.
14. Phosphoric acid, a protease-cleaved peptide fragment derived from one or more selected from the group consisting of type I collagen, alpha-2-HS-glycoprotein, periostin, biglycan, and SPARC; Fertilizers containing.
15. The fertilizer of claim 14, wherein the peptide fragment loses the activity of the protein from which the fragment is derived.
16. The fertilizer according to claim 14, wherein the molecular weight of the peptide fragment is 10,000 Da or less.
17. Phosphoric acid, an inactivated peptide fragment having a molecular weight of 568 to 10,000 Da derived from one or more selected from the group consisting of type I collagen, alpha-2-HS-glycoprotein, periostin, biglycan, and SPARC; Fertilizers containing.
18. The fertilizer according to any one of claims 14 to 16, wherein the concentration of the phosphoric acid contained in the fertilizer is 280 mM or more.
